Podcast: Practicing the Medical Arts

Practicing the Medical Arts

Full Transcript

This transcript was automatically generated, please excuse any errors.

Yoshino:

Hey everyone, welcome back to Artist Decoded. This is your host, Yoshino. And, this is yet another Mind/Wave episode. These episodes have been transforming over the course of time, but mainly my intention for these episodes is that I want to explore various modes of thinking. And, I want to hopefully give people an access point to create positive mental health routines. I’m a firm believer in conscious decision-making and in creating a solid foundation for self-reflection, self-care, and self-growth. Creating good habits in all aspects of life is extremely important, which takes a conscious effort to do so. I personally work out about 12 times per week, so that’s twice a day with one day off. I lift weights in the morning and do calisthenics in the morning, and do my cardiovascular activities such as walking, running, and cycling before sunset. I also know from personal experience that good habits, both physically and mentally, have to be developed slowly and over time.

This can be holistically compared to creating a solid foundation for a career in the arts, or just simply having an artistic practice because not everyone necessarily needs to have a career in the arts. But either way, this takes a conscious, consistent, and concerted effort to continue your craft. Which can be likened to anything in life, including developing positive mental health practices, which leads me to my guest for today, Dr. Bruce Hoffman, who is the founder of the Hoffman Centre for Integrative and Functional Medicine.

So let me tell you a bit about Dr. Hoffman. Dr. Bruce Hoffman did not choose the medical arts as a vocation. Originally, he wanted to be a writer and poet. His interest in health and healing developed later in life after a long and winding road of self-discovery, life experience and learning. He only applied to medical school so he could complete a residency in psychiatry and subsequently study Jungian analysis to understand the human condition and behavior. As life would have it, his destiny took him on a different journey. He never did formally pursue a psychiatry residency or Jungian analytic training, but his love for art, poetry, and psychology remains.

Dr. Hoffman was born and educated in South Africa and obtained his medical degree from the University of Cape Town. After two years of compulsory military training, his distaste for the local regime convinced him to immigrate to Canada in 1986, where he pursued family medical practice in rural Saskatchewan, Canada. Once ensconced in the practice of family medicine, he quickly realized that his interests in medicine were broader than just drugs and surgery. The allopathic medical practice was limited to treating symptoms and illnesses, but failed short in restoring the patient’s health entirely. Bruce embarked on a journey to understand what constitutes the human experience. What are the triggers and mediators that perpetuate human suffering? He wanted to assist his patients not only to be free of disease, but to realize their maximum potential.

Well, I hope you all enjoy this podcast episode. There’s a lot of rich information here, so stay tuned for that. But before we begin, please go to our iTunes page, leave us a review. It helps reviewers just like yourself to hear about the podcast. We’re also now on YouTube. There are a lot of new videos and content from past episodes up there. So, check us out over there and be sure to tune into our no wave cinema conversations on Clubhouse. The next conversation will be with me and Justin Dasher Hopkins. We’ll be talking about the classic 1964 Hiroshi Tasha Guevara film, Woman and the Dunes. We will be having this conversation on Wednesday, April 7th at 6:00 PM Pacific Standard Time. So definitely go check it out and listen to us over there. Maybe even contribute to the conversation as well. So anyways, without further ado, here’s my conversation with Dr. Bruce Hoffman. Hope you enjoy it.

Dr. Hoffman, thank you so much for taking the time to do this. And the main reason why I want to bring you on is to talk about good mental health practices and as Maslow would put it to hopefully reach self-actualization. And I think it’s really important for people in general, to be honest with themselves about every single aspect in their life, to live a holistic practice. And I was wondering if you can speak about your early pursuits for wanting to become a writer and poet and how that eventually led you down a path of studying traditional medicine.

Dr. Bruce Hoffman:

Sure. I was brought up in apartheid, South Africa. And initially in quite a conservative traditional home. But at a young age, when my parents got divorced at around age 10, my mother drifted off into more creative endeavors and found herself hanging out with Keith Anderson, who was a head of a circus, also an artist, a set designer with the opera company and the director of the opera company. And so, I found myself hanging out with Keith and his group of merry pranksters, if you will, because they were circus people, artists, creatives, and opera participants. And I found myself as a trapeze artist in a circus that traveled around South Africa, hanging out with these rather unique individuals, clowns, dwarfs, transvestites, just a crazy band of merry pranksters, which at a young age in conservative South Africa was completely unheard of.

So, I was exposed to alternative lifestyles from a young age. But then when my father got wind of this, he sent me off to an all-male boarding school, a thousand miles from home. And when I got to this all-male boarding school, they took one look at me and said; Hoffman, we’re going to knock you back into shape. So, then I was forced into this narrow, masculine boarding school mentality, and I was horrified it was like the worst thing that ever happened. But the school was an outward-bound school based on the boarding school that Prince Charles went to Gordonstoun and Prince Phillip went to. Just based on those same principles, go out into the mountains and find yourself. But after a couple of years of being at a boarding school, I had a school teacher by the name of Roger Loveday. And Roger was a devotee of a guru called Ramana Maharshi. He exposed me to the teachings from India and particularly the subset of Hinduism called  Advaita or non-dual Vedanta. And also at the same time, I got exposed to the writings of Jung; Memories, Dreams, and Reflections- his autobiography had a huge impact on me. And what ended up happening was I had a satori experience.

One day, Roger was speaking to me outside the school, outside the classroom, after he’d given a big dissertation on the bible and Christianity. After I was very cynically inclined at that time. I said to him; Roger, you don’t believe in all of those myths, do you? And he said to me, “of course I do”. And in that moment when he said, of course I do, I had a sudden awakening. I went into the state called non-dual state or satori. And, that’s where all space-time sort of, linear time disappears and you see behind the curtain, so to speak. You see the appearance of reality through the quantum lens, which is, there’s no time, there’s no future, there’s no danger, there’s no fear of death. Everything just dissolves into this oneness and where everything’s light. Which is well-documented in all the literature, many people have had these experiences. But that then set the stage for further exploration of these principles and these studies. I just continued to be inspired by the fact that there was a reality behind the reality that the rest of the world was operating on.

And then my mother applied for me to go to medical school, unbeknownst to me. Why, because she had a friend who had a friend who could get a scholarship for medical school, for somebody from the particular part of the country that I came from. So, she applied and I was actually up in Johannesburg building sets, scenery for a play with Keith Anderson and his group. I got a phone call and my mother said; Oh, by the way, you got into medical school. And I said, what? What’s medicine, I’m go to do what? She said, no, you got to go study medicine. I said, are you out of your mind? I want to go and study literature. Anyway, I ended up going to med school and not knowing what I was doing there. It is quite a peculiar experience. But while I was in medical school, I happened to go and stay on a remote farm up on the mountain. And there were a group of people around that area who were very influenced by the beat poets, Kerouac,  Ginsberg, et cetera. And I started to read them with great sort of joy. And, and then I ended up in my second year of med school, going to San Francisco and started to hang out with Gregory Corso and a lot of the other beat poets. And that was another inspiration for me.

I just got involved in creative endeavors, integrating Jung and Eastern thoughts and philosophies, and then finished my medical training, ended up in rural Saskatchewan as a family practitioner and really loved being a doctor, when I actually discovered what being a doctor was, because I had no clue. But then after a period of a year or two, I realize that this whole N2D2, name of disease, name of drug method of practicing was ridiculous. Even though it serves a function. And then I came across the writings and the videotapes of a medical writer and thinker called Larry Dossey. Larry Dossey had explored the interface between Eastern philosophies and Western medicine. I’ve written quite extensively about it. And, I watched his video and I was like completely moved. I realized that; Hey, I can bring back everything I learned in my youth that I thought I had to leave behind forever into the integration of this kind of medical practice. I flew down, met Larry Dossey, at a conference, had dinner with him. Very inspired, and then started off with that. To eat, discover, and study anything I could across the whole spectrum of medicine. Healing and the healing arts, including anything that could help an individual live at their maximum potential.

People enter into the medical office. I’m sitting in my medical office. I’ve just seen patients this morning and they come in with symptoms of depression, mold illness, Lyme disease, mast cell activation syndrome, a whole host of chronic fatigue or whatever. Then you start to work with a bigger lens are really entry points into a much greater dialogue and a much greater roadmap that you need to bring to the table in order to assist the person through this transformation of illness to wellness. People think they have a disease in which they label, and they think that’s where it begins and ends. But in the system I use and the method I’ve employed, and I’m proud to say that some of the success I have is that I employ a much larger roadmap. It was a much larger set of tools and hence have written about this new curriculum that’s necessary in order to interface with complex patients who can’t just be mechanistically reduced to a diagnosis. It’s actually absurd when you start to think of it. We’re just not trained to think with a different paradigm. We’re very mechanistic in our thought process, but there’s a lot more mystery that goes on into diagnostics and treatment.

What happened after that was that I started to study Chinese medicine, Ayurvedic medicine, homeopathy and German biological medicine, and the the sub-disciplines. And, happened to spend number of years with Deepak Chopra and David Simon. And when I discovered Ayurvedic medicine, they had an explanation of the different layers and levels of what they consider to be human reality, which is stepped down from soul to spirit, to mind, to emotion, to energy, to physicality, to outer world, out there, the expanded universe.

And I started to use that diagnostic model to think of human behavior and illness. And now I’ve incorporated that and expanded that and happened to also, at the time, meet up with a German doctor who’s still alive and still very active, Dietrich Klinghardt. He had also thought of these things and integrated some of these systems into his roadmap. And then I just expanded the roadmap. And now I use the Seven Levels of Diagnosis and Treatment TM across all layers and levels. And when a person enters my room, I use western diagnosis and their symptomatology as an entry point into a much wider dialogue and a much wider diagnostic and therapeutic potential roadmap. So that’s how I work nowadays.

Yoshino:

In terms of just like a, I want to say like a global scale, but I guess, you know, some of the pitfalls for allopathic medicine and the way that it’s practiced in a Western context, like what are some of the things that you’ve observed that needs to change within that context? And how do you think that you implement it in your particular practice?

Dr. Bruce Hoffman:

Well, being a trained western MD, I have the fortunate privilege of being able to look at disease through that lens. And the pitfalls are that the Western diagnosis implies that an organ system gets diseased, then you must find a pharmacology or a therapy or a surgical treatment for that. That is often the case, as we know. Sometimes when you got pneumonia, you want to get intravenous antibiotics, nothing wrong with that. But now we have a whole new paradigm upon us of complex multi-system multi-symptom disease presentations. And that model, that DSM- 10 classification of organ systems and pharmacological interventions is hopelessly inadequate to address those complexities. And it’s quite uncanny really when you start to work with complex patients as to how often western medicine gets it entirely wrong. And it’s only because their tool bag is so limited, it’s this perception that human beings are these mechanistic beings that, a little biochemical particles, that disease just falls out of the sky. And then you got to find a drug to kind of turn down the symptom.

Yoshino:

Do you think that that’s more of a systemic issue or what do you think the actual issue there is?

Dr. Bruce Hoffman:

Well, we think of human beings as being physical bodies, mechanistic bodies. So, it’s the paradigm, it’s the lens through which human beings are observed. That becomes a limiting factor. And we think diseases just fall out of the sky. There’s no antecedents, mediators, and triggers over the inflammatory disease process that is constellated. And we now know generationally, people exhibit, as you spoken with Mark Wolynn, people can come and present with disease processes that the initial triggers have been three generations before they were even born. And that epigenetic transfer of data is real. It’s studied at all the major universities. So that isn’t taken into account in the mechanistic model and the drug-based model. 5 minutes, 10 minutes, what diagnosis, what symptom cluster, what drug, boom. And in America is even worse because your insurance companies control what goes through the gates. And it’s ridiculous. I mean, it’s silly. It’s not how it works.

Yoshino:

Yeah. I think in America, it’s more capitalized, but that’s just part of the whole system. So pharmacologically, it could be traced from that. And also like the way that the educational system is structured as well.

Dr. Bruce Hoffman:

Yeah. It’s a disease-based model, it’s a mechanistic model. And the only therapeutic input that’s of any use is pharmacologically based, and the gateway to that is controlled by the drug industry and the drug lobbyists. It’s very bizarre how it’s all got set up. It’s very peculiar really. Because it’s not real. The human body is the final resting place of every incoming influence. And every top-down influence. The hidden and the obvious. And the body is the final kind of resting place of an individual for all of those influences. And if you don’t start looking at the toxicological logical input of a very diseased planet, the genetics of the individual, which can either detoxify or not that process. And then the influences of the energy body, because we basically, our DNA emits light, which then stands as a standing wave around us, either coherent or incoherently and is highly affected by electromagnetic fields. If you don’t take those things into account, and then the emotional influences we bring up from early childhood, we know from all the literature that children that have been either suffered from abuse trauma, or neglect trauma. Neglect trauma being often more damaging than abuse trauma. They have an infinite amount of increased disease processes later on in life. So, the environmental body, the physical body, the structural body, dentistry, chiropractic, if you don’t take all of those moving parts into play.

Like today, this morning, I saw a woman with a headache, but she had a bite misalignment. She had an overbite, with TMJ issues, had root canals, implants, and had a swollen back of the throat, which we call a Mallampati grade four with sleep apnea. I’m not trained about dentistry as a medical practitioner. I wouldn’t even look in the mouth as a doctor, but its obvious that her dentistry was playing a huge role in her headache presentation. I would just find a drug to treat the headache if I’m using my western practice.

So, the structural piece, then the energetic piece, and then the emotional piece, and then the ego development of the individual. The first half of life, ego structure, which takes us out into the world to become something that drives the first half of life. If we don’t know the internal dialogue of that person, the defenses they develop in order to stay safe, the thoughts that they have, the beliefs that they carry, the value systems, the hierarchy of values that they have. If you sitting in front of a patient and you don’t know their hierarchy of values, you can’t treat them because if their health is a fourth on their value system and running their businesses is the first on their value system, guess what? You have chaos in your low value systems, and you have order, you run your business well, but you’re going to delegate your health to your wife. And you’re not going to show up for all that’s required for you to transform your life. So, if you don’t know the hierarchy of values of people, you can’t really effectively relate to them where they are. Because they will come in and say, they want to feel better. But when you examine their hierarchy of values, it’s fourth on their value list. And unless they raise it, they’re not going to achieve any ends.

Yoshino:

Yeah. I think that’s really important to bring up because, even in that ICI presentation that you were giving, you were talking about how traditional allopathic approaches not taking into account different states of consciousness. And, you know, you could speak obviously more about this than I can, but I’m curious, how would you diagnose someone that doesn’t really take their health into consideration, but is more focused on maybe their business and work and value that as like something that is more important?

Dr. Bruce Hoffman

Oh, I take a history and I have a questionnaire. One of my set of questions, in my 70-page questionnaire, is determining your hierarchy of values. And I ask the question; how do you spend your time, your money, your attention, what you talk about, what you’re surrounded by? And if somebody says, well, I get up at six in the morning, I go to work. I talk business all day. I come home along the cell phone, I’m doing business deals and I’m surrounded by financial books and I watch business TV. It’s pretty obvious where their hierarchy of values is. Well, you got to “rob Peter to pay Paul”. If you want to get your hypertension under control, and  your diabetes under control, how much time are you going to devote to exercise, diet, meditation, sleep, et cetera? And they go, I’ll do my best. I’ll do my best, usually means not much.

Unless you’re inspired to have health as a high value, you have to be motivated from the outside, not inspired from the inside. Motivation lasts six weeks and then you give up, you can’t sustain somebody else’s value system to motivate you if it’s not inside of you.

Yoshino:

Yeah. It’s kind of like that traditional saying, you can lead the horse to water, but ask to take a sip. Maybe sometimes a much bigger sip. So going back to non-duality and speaking of…

Dr. Bruce Hoffman:

Hey, can I just say something? Sorry Yoshino, can I just say something quick just before we leave that subject. Mahatma Gandhi said that the problem with Western medicine is it works. You know, he said that. If you’ve got heartburn, you take a PPI, you take Pepcid, it goes away, nothing to do with what you ate before, how much you drank, blah, blah, blah. So people just take a whole bunch of suppressing drugs and they get on with their life, which is fine. But if you want, if you value health and wellbeing, you want to do a lot to get where you want to be. There’s this whole new group of younger people who are called bio-hackers, who make it their life’s work to study all that it takes to sustain a healthy cell membrane and a healthy internal milieu of the mitochondria. And a brain functioning and sexuality and libido, and they just devote the whole life to enhancing that. And that’s a full-time job. So, there’s is a gradation of what you can expect from a patient from just take a few supplements, to really devote your life, to turning your life around from a health perspective.

Yoshino:

But going back to the non-duality approach, how do you at the Hoffman Centre integrate that into the practice of educating people that are your patients, and then also integrating those more nuanced approaches with allopathic approaches and Western medicine?

Dr. Bruce Hoffman:

Well, the non-duality concept can’t be taught as you know, it’s either happens or it doesn’t happen. You either wake up to non-duality or you don’t. And it’s one of those strange events that other people experience or don’t experience. That’s when you start to see reality from behind, you see it with what they call One Mind. There’s no dual mind, there’s no you and me. We are just part of the same consciousness. Everything is consciousness, and that can’t be taught. Many gurus have set for decades on their stools, talking about the fact that the very thing you seek is preventing you from finding it. So, the very seeking prevents it, it just happens. But that’s a non-dual, that’s Level Seven in my model. But then there’s the other levels which I integrate in my model of assisting people achieve maximum potential within the realms of the dual life. The non-dual part is it can’t be imparted. It happens or not.

Yoshino:

Can you break down your seven-step method, essentially? I’m curious what exactly is in each part of the system.

Dr. Bruce Hoffman:

So, the Ayurvedic or Vedantic breakdown of human reality is we arise from Brahman. The one mind, the unified field, which we call spirit. You won’t be able to see this and I’m not going to attempt, but I sort of broken it down like this. Spirit, soul, intellect, emotion, electromagnetic, physical, extended (bodies). And on each of those stages, each of those layers of an individual’s reality, there’s definitely experiences, anatomical, designations, sciences related, diagnostics and therapeutics. So that’s the system I use. If you look at my website, I believe there’s a chart there, or that ISEAI lecture. That’s a system I practically use in order to assist people and get better. But they all enter through the physical, they come with a diagnosis and their symptomatology. And then I look at all the environmental influences, the biochemical imbalances, the genetics, the structure, the brain, I do, I have a brain treatment center. So, we’re always looking at brain function. And the electromagnetic, heart rate variability, et cetera. And I take a history of early developmental trauma. And then I look at ego structures and defenses and if need be, I send them for psychometric assessments. And then for the soul piece, for the family soul, I use a genogram and do Mark Wolynn’ s work or Bert Hellinger’s work, family constellation work. And for the individual soul, do dreamwork and Jungian type approaches.

So at each layer, there’s different ways of perceiving and experiencing human reality. And so, in a two-hour consult, you’re doing your best to sort of take as much in as you can to get to know that person and where the major blocks are. So even if they come in with Lyme disease, sometimes it’s a question of inherited family trauma, that’s really running the show. Or sometimes it’s due to a traumatic brain injury and they need brainwork. Sometimes it’s all layers, all levels. So having done this for a long time I sort of getting get better and better making the diagnostic and therapeutic recommendations.

Yoshino:

Can you talk a bit about your success stories with this process? I like to understand that a bit.

Dr. Bruce Hoffman

Well, all cases in the end sort of blur into one. But you know, there’s endless amount of patients that present with, say a diagnosis of Lyme disease or mast cell activation syndrome, who believe that that’s the only reason why they are sick. But when they start to explore all the other potential diagnostic possibilities, they all of a sudden realize that that was truly a teleological entry point into a much larger dialogue with themselves. And then they start to explore the whole of their lives and they start to make the necessary adjustments. I’ve got case histories in my upcoming book. I can’t pull one right now because this sort of endless variety of different presentations that I see on a daily basis. I mean, it’s just one little thing today. I saw somebody just very recently who was in her thirties, failed marriage, young child, no direction in life, presents with depression.

Her diagnosis is depression, on antidepressants. And could I help her with her depression and poor self-esteem. Upon further inquiry I found out that she’s moving back home with her parents at the age of 38. And she was very ashamed by all of that. At 38, I don’t know what I’m doing. I’m going back home. What a tragedy. And the man she just divorced, was castigating her for being hopeless, no good, et cetera, et cetera. But when you take a deep inquiry, you see that this soul has had interrupted bonds with her mother at a young age. Mother was separated from her for six weeks. She had a very poor diet. When she went to her mother in teens with developing puberty, her mother was offline, and didn’t see her. She never felt seen. And then she had the series of events, sexual abuse, medication and drug abuse, and then never really found her calling.

So, subsequently turns out that going home to mother and father at age 38 was an opportunity to actually reconnect and heal the interrupted bonds that she’d never been seen in heard for in the first half of her life. So instead of being castigated and feeling so ashamed, she now sees this as an opportunity to reconnect with her mother and father in a truly humble way where the parents, carry the greater weight, and she’s the child. And she can go back and start to integrate her life with her mother’s life and her grandmother’s life, both of whom were artists. She was a makeup artist, but always thought that her makeup career had nothing to do with art. But when it was reframed that she was disconnected from the feminine lineage and her makeup artistry was a continuation of that lineage, she all of a sudden blossomed into the realization that she was part of that maternal lineage and she need not be ashamed of it.

And even though she’d put the makeup artistry aside because of her child and she has to take care of the child because the hours were wrong, she realized she could always pick it up again, and she could step into that female lineage. And she did have a calling. She thought she didn’t, all of a sudden, she knew her whole calling was still on that feminine lineage. Her mother had had a transformation and had said to her; “darling, I realize I didn’t see you when you were younger. I apologize for that”. And all of a sudden, she had this entry into this greater feminine lineage that she could not use so she can pass on to her daughter. So, the daughter doesn’t feel as strained and shameful, et cetera, et cetera. So, yes, she’s depressed. She’s depressed because he’s in an existential crisis of not knowing. She was floundering in life, but she had all this opportunity that’s presenting itself. If she just turned the switches and started to see how it was all part of a grand design that was going to help her realign with her life calling. So, it just gets reframed in a new context and all of a sudden, the life force opens back up.

Yoshino:

Yeah. So, can you speak about the neurological significance of reframing, perceived negative events in one’s life and then transforming them into something positive in one’s mind?

Dr. Bruce Hoffman:

Well, the way I was introduced to, it’s a combination of neuro-linguistic programming and Jungian psychotherapy done cognitively, strangely enough, was through the work of a person by the name of John Demartini. And being exposed to his work, I was able to see how the perceptions that we take into life are often not real. And he uses this teaching tool. He says, look, basically in the quantum world it’s all light. Light gets broken down or dumbed down into matter. Matter is both equal positron and electrons, it’s got both sides. Our lower mind, which always seeks pleasure. One side is always excluding the other side. We always looking for dopamine and trying to avoid pain. And he says, the lower mind can see both sides simultaneously, but you can train your mind to see the integration of both sides to any event, if you just train it. It’s a cognitive restructuring of your mental processes. So, I learned how to do that. I learnt his methodology of how to re-perceive reality through non-dual, if you will, both sides, eyes. So, any event in the future, which looks disastrous, you start asking yourself, where is the upside to this so-called disastrous event? Anything you judge very negatively, like if you judge somebody with very negative trait, you’ll find out where you have the trait, how that trait serves, how that person’s negative trait is benefiting you. It’s not just something that should be a thorn in your side. And how, when you being challenged by a so-called person, who’s is sort of challenging you, where are you being supported? The universe is constantly in this flux of support and challenge, positrons and electrons, which is the basic nature of the quantum reality.

If you can train your higher mind to collapse the world into its opposites, as quickly as possible, you can stay poised in what John calls love. And love to him is just a synthesis of all opposites, where you see both sides simultaneously. And there’s no judgment or no lowering yourself into black and white unipolar perception. So, I try and assist patients like “you going home to mom, this is the most terrible thing at 38, but what is the soul wanting of you? “What is being asked of you? And once I took a history after, she came in saying that this is a horrible thing. She felt so ashamed. She left, she couldn’t wait to go home to see her mother to reconnect because it was reframed. She just saw how it had served her soul’s experience. It was necessary to go home, to receive the love of the mother in a new light, because she had had interrupted bonds all her life with mother. Her mother was ready. She had to be ready. She had to shift the perception from negative, to not positive, but just as opposite. As soon as reframed, boom, I’m going home. Thank God.

Yoshino:

No. Yeah, definitely. I mean, that’s a beautiful story, but I think, especially in the metaphorical sense, you know, when you think of a situation such as a purgatory situation, you can even think about it in certain ways, in a biblical context or in many different stories of purgatory. But we sometimes put ourselves in that purgatory by not seeing the positive association that could be taken out of that negative or what we perceive, quote, unquote, “as that negative lesson of the past”. And if there was something negative that happened the past, if I could say, Oh, that actually helped build my character for who I am today. And then constantly frame it in that context, you can find those lessons. But all those lessons are always there screaming at you to essentially, show themselves in a way that can benefit you. This is at least from my observations.

Dr. Bruce Hoffman:

Yeah. I have the firm belief that every experience that you have, whether it’s positive or negative is serving the projection, the evolution of your life experience. You sort of born over here; you die over there. The acorn does become the oak tree. The acorn needs the wind, the sun, the stresses and support of the environment to become who it’s meant to be. And, I’ve no doubt in my existence, your voids, the things you find most missing, the things you judge the most negatively actually become your highest values. In the end, you look back and I have the unfortunate and fortunate privilege of being in my second half of life. So, when you’re more soul based than ego-based not that you, without ego, not saying that, but you’re more trying to integrate the parts of you that you left behind in your pursuit and the drives of the first half of life when you’re driven. Adler drives, Freud’s drives, that you’re driven to become something in the first half of life.

And then in the second half of life, you try and pick up the pieces of the parts you left behind. And you try and reintegrate your authentic, innate self. And, in that process, you realize everything that ever happened to you was in service of your soul. There was never a mistake. You never were out of purpose for your soul’s trajectory. Nothing ever occurred to you that wasn’t in service of yourself. You have no regrets. And there’s nothing to forgive because everything was in service. Forgiveness is a ridiculous concept because it’s implying that, that one was given to you was wrong. And now you must forgive them. No, everything’s in service. Thank you for giving me that experience. Forgiveness implies I’m bigger than you. What you did to me, you were wrong, I’m right. And now I’m going to forgive you. How dare you, you know. Say, yes, thank you for giving me that experience. It’s always in service of our soul.

Yoshino:

So, speaking specifically about that forgiveness and you speak so passionately about it, but you know, if someone is suffering from some sort of shame or guilt, what sort of questions would you prompt to them to be able to have them question that shame and guilt and where that comes from. I’m curious about that.

Dr. Bruce Hoffman:

So, guilt is the perception, that in the past you’ve done something that’s caused others more pain than pleasure. So, the only question you need to ask is where do you think that experience that you gave that individual, where did it serve them? How did they perhaps benefit from that experience? Could you please look in the seven areas of their life? We have spiritual, which is our calling. We have relationships, social friends, we have health and beauty. We have careers, we have making money. And we have intellectual, mental development. If you feel guilty by some act you’ve done, it’s incumbent upon you to ask; where do you think that person benefited in those areas of their life that served their evolution? Keeping in mind that everything serves, everything is in evolution of the soul’s progression. So where might it have served them? Not where did it damage them? We know that there’s both sides. Yes, it was maybe painful to them, but how did it serve their evolution in the end? And if you ask those questions, which of the seven areas did they benefit, you could find? Some people because of pain, you’ve caused them, branch out and start to develop. They read, they go to courses, they connect with their family because they sort of destitute and in pain that they have to reach out to whoever they can. So, they start forming relationships back with strange family members. They form new friendships. They go online, they go to self-help, they go to retreats. They build careers around the adversity that you caused them. So, at the end of the day, you’ve got to ask the right questions of individuals.

Nobody suffers without gaining. If it doesn’t exist, the universe is not one sided. It doesn’t work that way. Which brings into question the whole victim mentality of “I’m a victim”. No, I’m not, this can provoke a whole outlandish backlash that victims will be up in arms but if you look through the lens of moral and ethics, yes, there’s victims and perpetrators. I’m not questioning that. But if you look through the eyes of the soul, there’s a balance there that’s evolutionary. And, if you look through the right lens, you can see an evolutionary projection. It’s just how I tend to see the world.

Yoshino:

No, that’s great. And I think that it’s interesting because of your background in more traditional western forms of medicine. And also, how you combined the western perspectives and also these eastern perspectives. Or what would be deemed as western and eastern. And, you’re able to eloquently, within practice, like what you do at the Hoffman Centre within practice, to be able to mold these things. And even on your bio, you said writing and poetry, which led you to the medical arts. I think that’s very important because that is what you do. Cause you’re essentially utilizing all of your experiences, your own personal pursuits, such as your pursuit of literature and poetry. And letting that inform you in a way to ask the right questions of your patients. But at the same time to ask the right questions of yourself.

Dr. Bruce Hoffman:

It’s so important Yoshino that you know to stay in an inquiring mode, a student mode. And once you have the privilege of having lived longer is you start to see patterns and trends. You’ll see an individual present with anxiety and OCD and anorexia and so forth and so on, and like a young woman in her thirties. And then you’ll see this archetypal trend that exists that she’s addicted to perfection. And she’s following the value system of a patriarchy, which is inculcated. And she’s introjected somebody else’s value system, like an overbearing father and wants it to achieve. And you see these archetypal trends emerging in your practice. And that’s based on reading, is based on literature, is based on knowing. In the ancient Greek temples, once you’ve gone through, this is in my lecture, the outer healing and the inner healing, you are then sent out into the theater where you watch Greek tragedies, which were archetypal or depictions of life. And you see these trends occurring. You see these people in certain stages. If you don’t know the stage of life the person’s in. Your first half of life patients, very different from second half of life patients. They’re not the same. They’re different flavor, different. You approach them differently. You got to be sensitive to the stage of life. And if I wouldn’t have known that. If I hadn’t been exposed to all these different paradigms of insights.

Yoshino:

Uh, I’m curious. You were speaking of liking essentially, or interested in Jungian philosophy, but also have you read a lot of Joseph Campbell? I’m sure you have.

Dr. Bruce Hoffman

Well, when I first got interested in Jungian work, Joseph Campbell was very popular. He had that PBS series, I think, in the 90’s…

Yoshino:

Power of Myth. Is that right?

Dr. Bruce Hoffman

I don’t know how old you are, Yoshino. Hahaha

Speaker 5:

No, I’m 34.

Dr. Bruce Hoffman:

You probably were. But, Joseph Campbell did the Power of Myth. It was everywhere on PBS. And we watched that series. I’ve got all the videos. We have all the VHS videos of that. I still have that.

Yoshino:

I know I’ve seen them.

Dr. Bruce Hoffman:

I still got them in my library right there. And I read his books and yes, very moved, very beautiful. He was a big influence.

Yoshino:

No, I was just curious, because you were talking about seeing certain patterns and archetypes.

Dr. Bruce Hoffman:

You do see them; you see them over and over again. It’s quite uncanny when you tune to those archetypes. And, you can see when a person is presenting with symptomatology, when it’s got nothing to do with the western diagnosis. When it’s actually a calling from the soul to wake up to a deeper transformation, that’s being asked of them. And you just get used to knowing how to have that dialogue with people and when to watch out for signs and symptoms. And know that, oh, the Lyme disease is not Lyme disease. It’s the fact that they are misaligned with, they haven’t integrated an aspect of themselves, which is calling to be integrated. They’re still living out the first half of life, dictates, which need to be given up at some stage. You can’t,  a 70 year old man in a Ferrari, that’s diagnostic. It’s just is.

Yoshino:

Yeah. I mean, I’m sure you can see many examples of that from either people that are also in your working profession or there’s so many examples of that. And, just someone having a Ferrari at any point of life, you just have to ask, like, what is the reason for that? You know, and also you can only drive one car at a time. They can’t drive two at a time, at least not from what I understand.

Dr. Bruce Hoffman:

Yeah, there’s all those clues, the history taking is filled with clues. And you just got to be sensitive to them and hopefully tuned in as much as you’re able to. And so that requires a whole new curriculum for the healers of the future. It has to be rewritten. The curriculum must be rewritten. Not to say that MDs must become healers. I disagree. Doctors should stay doctors. Stay with all that. Stay with a mechanized symptom-organ system- method medicine. Be very good at it, be the best at it. And leave them alone. Don’t ask them to become healers. Let’s have a new curriculum for healers. People are called into a different way of interrelating with their patients. And let’s have that curriculum outlined. And let’s co-exist with each other in equal exchange, which doesn’t happen. Doctors have this peculiar arrogance that what they’re not up on, they down on. And so, anything that doesn’t fit into that model, they tend to dismiss, which is unfortunate.

Yoshino:

Makes sense. I mean, it’s essentially breaking up the paradigm that if you believed in this certain way of life being educated by the system. And it creates a certain type of way that you think about the world and your perception of your space in it, essentially.

Dr. Bruce Hoffman:

Absolutely.

Yoshino:

I have one more question for you because I don’t want to take too much of your time and I appreciate you for taking the time to be on the podcast, but what sort of advice do you have for artists and creatives?

Dr. Bruce Hoffman:

Wow. I spoke to you before we got on,  that my great love is art. Now in the last 10 years, I rediscovered this huge passion, interests, and I was deeply moved by art and still to this day. Before I answer the question, I was estranged, I was South African living in Canada, and I felt deeply homesick. But as soon as I started to buy South African art with its imagery and symbology, I could bring it over and have it in Canada, I settled down, I had living symbols of my African heritage with me, and there was no such need to go back home. So, I mean, artists generally are tuned in, at a deeper dimension and they bring forth symbolic messages and are able to translate archetypal stories, like poets. When they tuned in and the higher their skill, both intuitive and skill, the deeper the symbolism, the deeper the impact on that, because we all resonate at some level with archetypal symbolism. It hits us like a break when it’s true. And it speaks to us.

So advice, I’m in awe of artists. I mean, those surrealists’ artists like Leonora Carrington. Oh, my goodness. I mean, what were they bringing forth? And what’s really going on. I’m fascinated. I believe some of their outer lives are maybe quite chaotic, but they sort of balanced it with this inner rock of their own unconscious that just pours through them. So, I think it’s an equal balance between outer neuroses, if you will. Then in a solidity and what a beautiful exchange, what a beautiful gift to humanity.

Yoshino:

Well, I mean that’s a sound observation. It sounds like you have a very deep love for and appreciation for the arts and what the arts can provide for humanity.

Dr. Bruce Hoffman

Yeah. Poetry. I mean, Mary Oliver, The Wild Geese. Oh man. When it speaks, it speaks and you just fall over into ecstasy. It’s so archetypally resonant. It’s just makes life meaningful. Provides meaning. It’s a beauty. Beauty and meaning.

Yoshino:

I agree. I agree.

Dr. Bruce Hoffman:

Have you ever seen that movie? The Great Beauty?

Yoshino:

I haven’t, no. When did that come out?

Dr. Bruce Hoffman:

Oh, it’s by that French (incorrect- Italian) director, Paolo Sorrentino. It’s about a man who gets to be in the 60s and nothing inspires him anymore. And so this whole movie is about him visiting sights and sounds. And is in Rome, all this opulence and decadence and nothing excites him. And he’s just like desperate. Until he realizes that at some stage he was moved by a great beauty. It happened to be in the form of a woman he loved. But all of a sudden, he just wakes up to some things that he’s left far behind. And he wakes up into another phase of his life, realizing how many years he’d lived in this outer world without connecting to his true inspiration. It’s a beautiful movie. Wow.

Yoshino:

You know, what that reminds me of,  have you seen Citizen Kane recently?

Dr. Bruce Hoffman:

You know, I saw it once and I read it. I’d read how perfect a movie it was. And when I watched it, I thought, what are they talking about? But after 10 minutes, I watched each frame and I immediately got the majesty and the marvelous sort of symmetry and exactness of the whole development of that movie. And I’ve got why it’s one of the greatest movies of all time. I just could see it just so obvious actually, you know, Jungian.

Yoshino:

Definitely. Well, I just bring that movie up because what you’re talking about specifically at the end of the film. I don’t think I need to say like spoiler alert because this film came out in, I think 1945 or 43, but at the end of the film he just keeps on saying rosebud. And then you find out what that symbolized to him. And so, I think, he does all these things throughout his life to attain power, to attain wealth, but then this was it, I believe it’s a sled when he was a child carried so much meaning and symbolism to him. And it’s just interesting how there’s that consciousness shift. So it just kind of sounded similar to the film that you were telling me about.

Dr. Bruce Hoffman

Well, now I’m going to watch both movies back-to-back and then keep that in mind to see the connections. Well, we live our lives through symbols and meaning in the end, the outer world is just a playground for meaning and symbol.

Yoshino:

It’s interesting. Just to leave you with this, but yeah. I’ve been meaning to crack open Jung the Book of Symbols. Is that what it’s called? I have it downstairs and I need to spend some time, cracking that open. But anyways, thanks so much for doing this and taking the time. I appreciate you for doing this.

Dr. Bruce Hoffman

Yeah, absolutely lovely. I’m going to look at your podcast and see what else you’ve done. That it is inspired me through your connection to the artists and artistry.

Speaker 2:

Yeah. You might like some of the artists, you know? All right, Bruce. Well, thank you very much. I appreciate it.

Dr. Bruce Hoffman:

Thanks for the talk. I appreciate the talk. Thank you.

Chronic Inflammatory Response Syndrome (CIRS) Evaluation and Treatment

Chronic Inflammatory Response Syndrome (CIRS) Evaluation and Treatment

Introduction

When a patient presents to a doctor with many symptoms, has seen many doctors, and has not improved despite many attempts by the most well meaning practitioners, both traditional and alternative/integrative/functional, it is time to consider whether a diagnosis of CIRS may be playing a role in his presentation. However, this decision can be complex. Unless a specific roadmap is followed and a process of deductive reasoning applied to a differential diagnosis, one may find oneself in a quagmire of conflicting information.

What will follow in this essay is a step by step map for health care practitioners to follow in the process of deductive reasoning in the consideration of whether CIRS may be underlying the patient’s presentation. Unless a practitioner follows an evidence-based protocol of carefully developed steps as outlined by Dr Shoemaker and others, one may be tempted to omit or skip specific steps in the diagnostic process thereby reaching conclusions that are not in keeping with the published research. Thus, it is vital to follow the steps exactly so to support or refute the evidence.

Health care practitioners must precede a diagnostic workup for CIRS with the normal workup one employs for chronically ill patients: present history, presenting symptoms, past history, family history, medications, allergies, supplements, surgeries, dental history, toxin exposure, review of systems. A cognitive and mood history is also essential. As a certified functional medicine practitioner, I am most interested in the timeline of illness presentation, as well as any antecedents, mediators, and triggers that may fall outside of the CIRS presentation.

However, if the patient’s symptom clusters point towards a possible diagnosis of CIRS, the diagnosis of CIRS must be included in the differential diagnosis.  It is then incumbent upon the practitioner to enquire as to whether or not there have been any exposures to the possible agents and/or biotoxins that are responsible for initiating this potential diagnosis and if so, to then follow the rest of the diagnostic criteria to establish the diagnosis.  

Questions to ask patients who have been exposed to water damaged buildings include: Do you/did you live in a building with obvious mold visible? Has your home ever been flooded?  Is there any obvious water intrusion? Do you smell musty odors? Does your home have condensation on the windows? Are there any water stains around your light fixtures in the ceilings? Did you feel worse after you moved homes, school, and work place? Has conventional air quality testing revealed mold spores present?

Further questioning includes: Have you had a tick bite, EM rash, severe flu-like illness that persisted after visiting Lyme endemic areas? Have you been exposed or swam in a body of water with an algae bloom? Have you ever been in waters/estuaries where sudden fish kills were reported through direct contact or inhalation of aerosolized or volatized toxins? Have you eaten reef fish and felt ill soon afterwards? Have you ever had a spider bite (brown recluse spider)?

Background Information prior to engaging in the diagnostic criteria

Immune System

The immune system is composed of two major subdivisions: the innate or nonspecific and the adaptive or specific immune system (found only in vertebrates). We are born with innate immune responses intact; we develop adaptive immune systems after birth.

The innate immune system is the body’s primary defense mechanism against invading antigens: the adaptive immune system is summonsed by the innate immune system as a second line of defense provided there are no HLA genetic defects in the individual (74% of the population).

26 % (1 in 4) of the population has an aberrant HLA system that leads to upregulation of the innate immune system with an inability to adequately notify and summons the adaptive immune system.

This defective setup informs the basic underlying issue with CIRS; an aberrant upregulation of the innate immune system due to biotoxin inducing triggers, with a defective adaptive immune response to these inflammatory signals

Innate System

  • Acts almost immediately to infection, the adaptive takes longer to respond
  • Is not specific to a particular antigen and reacts the same way to a variety of infectious agents and inflammagens.
  • Recognizes toxins with pattern recognition receptors
  • Does not provide long-lasting immunity to the host
  • Communicates with the adaptive immune system via macrophages/monocytes and dendritic cells as antigen-presenting cells, the first responders of the innate immune system
  • Recruits immune cells to the site of infection via the use of cytokines and TGF beta-1
  • Activates the complement cascade system to assist in removing antigens
  • Presents toxins to the adaptive immune system naïve lymphocytes called T cells, the lead cells of the adaptive immune system. These inflammatory molecules do not have a specific target and they do not remove biotoxins. Trichothecenes, the biotoxins released from Stachybotrys and Fusarium mold species can slow the maturation rate of dendritic cells, [1] resulting in defective antigen presentation to the adaptive immune system

Both aspects of the immune system have cellular and humoral components.


[1] Hymery N, Sibiril Y, Parent-Massin D. In vitro effects of trichothecenes on human dendritic cells. Toxicol In Vitro. 2006 Sep; 20 (6): 899-909. PMID: 16517116

Adaptive System

  • Provides long term immunity by creating immunological memory after the initial exposure to a specific pathogen or biotoxin
  • Adaptive immunity involves the destruction of foreign pathogens and presentation of their peptide remains to T cells to begin process of antibody production by B cells, and NK cells and cytotoxic T cells. [1]  The T cells teach the B cells to recognize and respond to invading toxins so that, in the future, if re-exposed, antibodies produced by the B cells can mount an appropriate antibody response  
  • In biotoxin illness, due to specific genetic HLA susceptibilities, the adaptive system cannot see the biotoxins presented to them by the innate system and thus cannot produce antibodies to neutralize them. The toxin isn’t recognized as foreign. [2] These toxins have a unique structure called “ionophores” that prevent them being metabolized or excreted. The innate immune system continues to create inflammatory cytokines, leading to dysregulation of multiple systems and thus the CIRS diagnosis 
  • Patients with CIRS have dysfunction of T reg cells which are converted into pathogenic T lymphocytes via the inflammatory cytokine TGF beta-1
  • B cells, the cells of TH 2 immunity, tend to fight infections and inflammagens outside of the cell and produce antibodies
  • T cells, the cells of TH 1 immunity, tend to fight infections and inflammagens within the cell and produce transfer factors. Transfer factors are made in a similar fashion to B cells antibodies [3]

[1] Ryan J, Shoemaker R. Transcriptomic signatures in whole blood of patients who acquire a chronic inflammatory response syndrome (CIRS) following an exposure to the marine toxin ciguatoxin. BMC Medical Genomics 2015 8:15

[2] Shoemaker R. Mold Warriors . Otter Bay Books Baltimore pg. 63

[3] Rappaport S. The Evaluation and Treatment of Chronic Inflammatory Response Syndrome. Pg 16

Case Definition of CIRS

Chronic Inflammatory Response Syndrome (CIRS) is a syndrome which was originally described and expanded upon by Dr Ritchie Shoemaker in the late 90s. To date, there are over 1700 scientific articles on this condition. 

CIRS is defined as a multi-symptom, multisystem illness caused by exposure to biotoxins or neurotoxins derived from a biological source. [1]  It is associated with a well-defined set of abnormal biochemical disorders and test results in genetically susceptible individuals.

In a 2013 paper, CIRS was described as a chronic, progressive, multi-system, multi-symptom syndrome characterized by exposure to biotoxins, HLA genetic predisposition, altered innate and adaptive immunity, peripheral hypoperfusion at multiple sites and multiple hypothalamic-pituitary-end organ dysregulations. [2] This inflammatory dysregulation can affect every organ in the body and if left untreated, can become debilitating. Diagnosis begins with a history of symptoms suggestive of CIRS plus a history of exposure to a known trigger. Once these criteria are established, a set of specific diagnostic biomarkers is undertaken to establish the diagnosis. 

Biotoxins are extremely small, fat soluble molecules capable of going from cell to cell through membranes without being carried directly in the blood stream rendering them impossible to find in the blood stream. Biotoxins can enter through inhalation, direct contact with contaminated water, ingestion, tick bites and spider bites. These biotoxins, in genetically susceptible people whose immune system (antibodies) do not recognize and tag them, lead to chronic inflammation and long lasting chronic illness. Biotoxins bind to certain surface receptors, particularly those on white blood cells (macrophages, monocytes and dendritic cells) called antigen presenting cells.

Pattern recognition receptors (PRRs) are a primitive part of the immune system. They are proteins expressed by cells of the innate immune system to identify two classes of molecules: pathogen-associated molecular patterns (PAMPs), which are associated with microbial pathogens, and damage-associated molecular patterns (DAMPs), which are associated with cell components that are released during cell damage or death. The microbe-specific molecules that are recognized by a given PRR are called pathogen-associated molecular patterns (PAMPs) and include bacterial carbohydrates (such as lipopolysaccharide or LPS, mannose), nucleic acids (such as bacterial or viral DNA or RNA), bacterial peptides (flagellin,


[1] Shoemaker RC, House D, Ryan J, Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health, 2013;5 (3): 396-401

[2] Shoemaker R.C. Ryan JC Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health 5 (3), 396-401

microtubule elongation factors), peptidoglycans and lipoteichoic acids (from Gram-positive bacteria), N-formylmethioninelipoproteins and fungal glucans, mannans, and chitin.

Endogenous stress signals are called damage-associated molecular patterns (DAMPs) and include uric acid and extracellular ATP, among many other compounds.[1]

This binding releases specific amounts of inflammatory molecules, cytokines, complement and TGF beta-1- the innate immune system activation sequence. This inflammation is not specific and cannot remove the biotoxins but result in persistent inflammation and a syndrome now known as CIRS.

Unlike bacterial or viral pathogens, which can be identified in blood work, biotoxins cannot be identified by routine blood tests and therefore one needs to rely on identifying them via the damage they inflict on the immune system, neuropeptide hormones and end-organ hormone systems.

Keith Berndtson MD, describes the structure of biotoxins in his Chronic Inflammatory Response Syndrome essay.[2] For example, cell membranes depend on ion channels to transport potassium, sodium and calcium ions in and out of cells. Biotoxins show the structural forms of amphipathic ionophores, creating ion channels that disrupt cell electrodynamics and hence the battery-like charge, rendering the cell incapable of performing its energy producing functions derived from the ion pumps. They also behave as “rogue” ion channels.

Biotoxins have both water and fat-soluble capacities. Biotoxins nestle on the inner fat-soluble membrane of cells, thus showing a predilection for fatty tissue like the brain, nervous tissue and the autonomic nervous system. Thus, they disrupt cell function without destroying the cell; as opposed to pore-forming toxins which create large holes in cell membranes, which are enough to kill the cell itself.

Cell-signaling is disrupted inside the cell by the disruption in the ion movement. The cell then triggers a defensive response by activating genes that code for inflammatory cytokines, on top of the already overworked innate immune system driven by CIRS. Elevated TGF beta-1 is a sign that the body is over revving from both an innate and an adaptive immune system T cell response.

CIRS biotoxins are first and foremost neurotoxins due to the fatty acid predilection with the brain being a common site, especially if there is porous blood-brain barrier.  Cardiovascular and GI sites are also common organ sites due to the rich nervous innervation and the fact that these biotoxins reside intracellularly in the fatty acid membrane, not accessible in the blood stream. They are difficult to dislodge particularly when the adaptive immune system is not adequately working.

Originally, the case definition criteria included Tier One and Tier Two criteria. All tier-one criteria had to be met and three of the six tier- two criteria had to be met to confirm the condition. As research progressed and deeper insights were gained, Dr Shoemaker updated his case definition in 2006 by including Tier-Three criteria which described the response to successful treatment.

 In 2008, the Government Accountability Office (GAO) issued their case definition, which was largely reliant on the published work of Dr. Shoemaker. It is the definition commonly used today. Dr. Scott McMahon at the 2016 Surviving Mold Conference at Irving, California, recommended that the GAO case definition be used in clinical practice.


[1] https://en.wikipedia.org/wiki/Pattern_recognition_receptor

[2] Berndtson K. Chronic Inflammatory Response Syndrome, 2013

TIER ONE CRITERIA – all three must be met

1. Exposure

The patient must have a story of an exposure to a biotoxin causing illness.

Mold – water damaged buildings (due to faulty construction, defects in ventilation, condensation issues, high humidity, leaky pipes, poor basement designs, flat roofs without adequate ventilation, fake stucco, faulty appliances, poorly ventilated bathrooms, front end loading washing machines) host microbial growth (bacteria, fungi, mycobacteria and actinomycetes) and produce over 30 different toxins and inflammagens (including mannans, beta glucans, hemolysins and proteinases). Toxic metabolic fragments and cell wall fragments from these filamentous molds are the major source of these biotoxins.

Mold is a specific biotoxin producing component of many water damaged buildings. In 2011, the National Institute for Occupational Safety and Health reported that 50 % of buildings have sustained water damage. Indoor fungi such as Stachybotrys, Aspergillus, Acremonium, Penicillium and Chaetomium have been implicated.

The Center for Disease Control (CDC) agrees with these findings, stating in a paper published after Hurricane Katrina and Rita in New Orleans, “Mold, endotoxins and fungal glucans were detected in the environment after Hurricanes Katrina and Rita in New Orleans at concentrations that have been previously associated with health effects.” [1]  Among the sources of biotoxins that can produce CIRS, biotoxins from molds known to grow in water damaged buildings (WDB) account for some 80% of the CIRS-related illness burden.[2]

Lyme disease- Borrelia burgdorferi infections produce a biotoxin (Bbtox1). [3]A history of a tick-bite, an EM rash, followed by a flu-like illness and the use of suitable testing (Elisa plus confirmatory Western Blot) is required to make the diagnosis. Lyme disease and post Lyme treatment syndrome remains a highly contentious area of investigation. Dr Shoemaker’s research showed that up to 21 % of the population is genetically Lyme susceptible, more likely to develop post-Lyme syndrome and less responsive to antibiotics for Lyme disease. They will be more likely to have an upregulated, persistent, inflammatory immune response due to the circulating neurotoxins, in spite of the bacteria being adequately killed by antibiotics.

A 2010 paper showed that Borrelia antigens may bind to pattern recognition receptors of the innate immune system and result in decreased CD 38 and thus decreased dendritic cell activation.[4]  Individuals thus have genetically determined defective protective antibody production and upregulated innate immune systems; they fail to respond to antibiotics, the definition of post-treatment Lyme syndrome (PTLS).


[1] Rao C, Brown C, et al. Applied and Environmental Micro 2007; 73 (5); 1630-1634

[2] Berndtson K. Chronic Inflammatory Response Syndrome. 2013. Pg 3

[3] Cartwright MJ, Martin SE, Donta ST. A novel neurotoxin (Bbtox1) of Borrelia burgdorferi. Meeting of the American Society for Microbiology. 1999 May: Chicago.

[4] Hartiala P, Hytonen J, et al. TLR2 utilization of Borrelia does not induce p38 and IFN-beta autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells. Journal of Immunology 2010 May 2015;184 (10): 5732 -42.

Invertebrate species producing neurotoxins including dinoflagellates (ciguatera and red tide), Pfiesteria (PEAS), and cyanobacteria- (freshwater blue-green algae Cylindrospermopsis and Microcystis – a genus of freshwater cyanobacteria) exposure. Ciguatera fish poisoning is the most common marine toxin poisoning worldwide with an estimated 50,000-500,000 cases annually. [1] Ciguatoxins are dinoflagellates of the genus Gambierdiscus found in numerous (over 400) reef fish such as barracuda, grouper and snapper with larger and older fish higher up the fish chain being the most toxic.

Poisonous spiders like Brown Recluse and Mediterranean Recluse spiders.


[1] Ryan J, Shoemaker R. Transcriptomic signatures in whole blood of patients who acquire a chronic inflammatory response syndrome (CIRS) following an exposure to the marine toxin ciguatoxin. BMC Medical Genomics 2015 8:15

2. Other Diseases

are ruled out via a thorough differential diagnosis workup. Patients with CIRS are often misdiagnosed as having depression, anxiety, PTSD, somatization, Alzheimer’s, Parkinsonism, allergy, ADD/ADHD, fibromyalgia and Chronic Fatigue Syndrome. If treated for these underlying conditions, it will make no difference to their underlying CIRS diagnosis. [1]


[1] Ryan J, Shoemaker RC, RNA-Seq on patients with chronic inflammatory response syndrome (CIRS) treated with vasoactive intestinal polypeptide (VIP)shows a shift in metabolic state and innate immune fluctuations that coincide with healing. Medical Research Archives Vol 4 Issue 7 2016.

3. Symptoms

  1. must be allied with the clinical picture as outlined by Dr. Shoemaker in numerous publications.  

Symptoms associated with CIRS (37 in number) are grouped into 8 organ system categories. Symptoms in at least 4 out of the 8 organ system categories (below) are considered diagnostic.

 The symptoms categories are listed in the table below:

  1. General fatigue and weakness
  2. Muscles – aches, cramps (claw-like cramping of hands and feet), joint pains, morning stiffness, ice-pick pains
  3. General – headache, frequent urination and increased thirst, night sweats, static electricity or shocks, appetite swings.
  4. Eyes – light sensitivity, red eyes, blurred vision, tearing
  5. Respiratory – sinus congestion, cough, shortness of breath
  6. Gastrointestinal – abdominal pain, diarrhoea
  7. Neurological – numbness, tingling, metallic taste, vertigo, temperature regulation, dizziness, tics, atypical seizures, fine motor skill problems
  8. Cognitive – memory loss, concentration difficulties, confusion, learning difficulties, difficulty finding words, disorientation, mood swings, anxiety, panic

These 8 categories are further organized in a questionnaire (below) into 13 symptom clusters. Each cluster has between 1-5 symptoms. The clusters were selected by statisticians in order to maximize predictive capabilities.  A patient presenting with at least 1 symptom in at least 6 of the 13 clusters for more than two weeks, needs to be considered as having the CIRS diagnosis and should have a thorough diagnostic workup. In adults, if symptoms are present in at least 8 symptom clusters, this is considered consistent with biotoxin illness. In children, if symptoms are in 6 symptom clusters, these results are considered positive.

Clinical questionnaire chart

Signs

Signs were not included in the Three Tier categories.

There are many possible clues on physical examination as to the possibility of a CIRS diagnosis:

  1. Red eyes
  2. Tremor – resting.
  3. Cool hands and feet
  4. Discolored hands and feet
  5. Pallor
  6. Weakness in the shoulder extensor muscles
  7. Decreased muscle strength in the arms and forearms
  8. Grip strength and shrugging of shoulders against resistance
  9. Hyper flexibility – Flexibility is tested
  10. A full examination of all systems is to be done, including thyroid, cardiac and respiratory systems[1]

[1] Shoemaker R. Biotoxin Illness Treatment Protocol Pg. 1

TIER TWO CRITERIA – at least three of the following six criteria must be met

1. Abnormal Visual Contrast Sensitivity (VCS)   

http://www.survivingmold.com/store1/online-screening-test

  • In 1997, Dr. Shoemaker and Ken Hudnell published a study demonstrating that patients with exposure to biotoxins showed abnormal VCS results consistent with biotoxin illness. The visual contrast test measures the neurologic function of the optic nerve from the retina to the cortex by measuring the least amount (threshold) of luminescence difference between adjacent areas (contrast) necessary for an observer to detect a visual pattern.
  • The test measures contrast sensitivity for five sizes (spatial frequencies) of light, gray and dark bar patterns (sinusoidal gratings). The VCS eliminates near, far, color, motion and peripheral vision variables.
  • There are spatial frequencies measured amongst healthy individuals which is the curve formed by the highest level of contrast the patient will see, versus the CIRS patients who will have lower contrast sensitivities and their curves will fall below the healthy control line. Higher contrast sensitivity is better.
  • In the presence of biotoxin illness, visual contrast sensitivity decreases. Only rows C and D count for scoring pass or fail. One must see 7 in each eye on C and 6 in each eye on D.  Rows D and C show improvement with clearing of biotoxins. With an intensification reaction to cholestyramine, there will be a fall in column E followed by a fall in column D. [1] A fail in 1 eye and not the other eye, still constitutes a fail.
  • VCS appears to be an early, persistent, highly sensitive, inexpensive and easily measured indicator for biotoxin illness.[2] Only 8 % of people with CIRS will have a normal VCS. Thus, 92 % of people with biotoxin illness will fail the VCS. However, 98 % of patients who fail the VCS test and who have 8 of the symptom clusters will have biotoxin illness.
  • A few people will pass the VCS but still show signs, symptoms, and inflammatory markers suggestive of biotoxin illness such as artists and professional baseball players with extra keen vision. [3] Occupational exposure to solvents, hydrocarbons and petrochemicals can cause a person to fail the VCS test but not have biotoxin illness. This phenomenon is rare.

For accuracy, the following conditions need to be met:

  1. Visual acuity must be better than 20:50.
  2. Patients must wear their corrective eyewear
  3. Lighting must be sufficient
  4. Patients must sit 14 inches away from the screen for visual acuity, 18 inches for contrast sensitivity.[4]

If a patient either passes or fails the VCS test and there is still a high index of suspicion for biotoxin illness based on a history of exposure, symptom cluster analysis and/or signs on physical examination, it is still advisable to proceed with HLA and inflammatory biomarker testing.


[1] Shoemaker R. State of the Art answers to 500 Mold Questions Question 212.

[2] Shoemaker R, Hudnell K. Possible Estuary-Associated Syndrome: Symptoms, Vision and Treatment Environmental Health Perspectives Vol 109. No5 May 2001.

[3] Shoemaker, 2011, June 27, DVD.

[4] Shoemaker R., Letter to St Barnard Parish, 2/22/2006. pg. 8

VCS test results

2. Human Leukocyte Antigen (HLA) Genetic Testing

  • Approximately 24 % of the USA population have HLA gene types that make them susceptible to biotoxin illness i.e.- they do not have the genetic capability to clear biotoxins. The susceptible population makes up 95 % of the CIRS patients. The remaining 5% of CIRS patients do not have this genetic susceptibility. Approximately 76 % of the population is not susceptible to CIRS.
  • HLA refers to the Human Leukocyte Antigen genes on chromosome 6. HLA’s are found on the surface of nearly every cell in the human body. They provide instructions for making a group of related proteins known as the HLA complex which helps the immune system distinguish between the body’s own proteins and proteins made by foreign invaders such as bacteria, viruses, and fungi. This gene encodes for proteins that present foreign antigens to immune cells for removal. The HLA DR test determines ones susceptibility to CIRS plus many other diseases. [1]
  • These HLA DR/DQ encoded proteins are found on antigen presenting cells such as macrophages, B cells and dendritic cells and they present foreign cells from outside the cell to naive T lymphocytes. The T lymphocytes eliminate the antigen and transfer to B lymphocytes the ability to identify the antigen for removal. The structures of the HLA DR molecules are critical to the initial peptide/antigen recognition. The alleles most important for chronic illness expression include DRB1, DQ, DRB3, DRB4, and DRB5.
  • Just as we inherit one red blood cell type from our parent, we also inherit white cell types from our parents. However, the proteins inherited are not just one or two as in red cell proteins; they are many more combinations of proteins into groups resulting in over 50 different HLA types. The chart below will demonstrate which haplotypes are associated with which biotoxin illness susceptibility
  • The following haplotypes are associated with these different biotoxin illnesses.
  • Multi-susceptible:  4/3/53; 11/3/52B; 12/3/52B; 14/5/52B
  • Mold specific: 7/2/53; 7/3/53; 13/6/52A, B or C; 17/2/52A; 18/4/52A
  • Borrelia specific: 15/6/51; 16/5/51
  • Dinoflagellate specific: 4/7/53; 4/8/53
  • MARCoNS susceptible: 11/7/52B
  • MSH low: 1/5
  • Mold- low risk: 7/9/53; 12/7/52B; 9/9/53

[1] Shoemaker RC. Johanning E. Sick Building Syndrome in Water-damaged Buildings: Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health, pp 66-77, 2005

HLA-DR Patterns

SusceptibilityDRB1DQDRB3DRB4DRB5
Multi-susceptible43 53 
Unable to clear an/all toxins from system11 or 12352B  
 14552B  
Mold72 or 3 53 
Unable to recognize or clear mold toxins13652 A, B, C  
 17252A  
 18*452A  
Chronic Lyme-post Lyme syndrome156  51
Unable to clear Lyme toxins165  51
Dinoflagellates47 or 8 53 
MARCoNS immune system lacks ability to recognize and attack methicillin resistant staph infections11752B  
Low MSH15   

Clinical Observation

  • 4-3-53 – has 12 subtypes DRB1- 0401, -0402 and -0404 are the worst, 3% incidence, the worst RA, malaria, autoimmune hepatitis. Have the highest C4a and TGF beta-1. 0401 is the worst.
  • 11/12-3-52B – 1% incidence, tall, hypermobile, long arm span, good athletes. With free/unbound TGF β-1, they get “sicker quicker” upon exposure.
  • 17-2-52 A,B,C and 7-2-53 haplotypes associated with celiac disease
  • If a Lyme patient does not have the Lyme or multi-susceptible haplotypes there is a higher chance that he will respond to antibiotics alone. 
  • If the patient is not better with antibiotics and he has one of these haplotypes, he will need a biotoxin pathway approach. Taking antibiotics for prolonged periods alone will not fix these patients.
  • Low risk mold HLA types are: 7-9-53; 12-7-52B; 9-9-53;
  • No recognized significance types are: 8-3,4,6. 1-5,6,8

3. Matrix Metallopeptidase 9 (MMP-9) 

Lab Results

Normal range: 85-332 ng/ml; 28.14-109.89 nmol/l

A prechilled SST tube is essential to use. Following the lab draw, the specimen should be immediately centrifuged and frozen. This step will prevent the release of MMP9 from the white blood cells into the blood specimen which can double or triple at room temperature in as little as 30 minutes. Use LabCorp.

  • MMP-9 is an enzyme activated by macrophages inducing inflammatory cytokines of the innate immune system that destroys the basement membrane of endothelial cells. This provides a barrier between the blood and tissue
  • With high MMP-9, as when the immune system is chronically stimulated, the basement membrane is porous, allowing inflammatory compounds/chemokines to penetrate tissues such as muscles, joints, brain, lungs, peripheral and autonomic nervous system.[1]
  • High MMP-9 will increase blood-brain barrier permeability. [2]

[1] Shoemaker RC. Defining Sick Building Syndrome in adults and children in a case -control series as a biotoxin-associated illness: American Journal of Tropical Hygiene and Health; 2005;73 (6):228

[2] Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, et al. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke. 2011 Mar 31.

  • MMP-9 can contribute to the destruction of connective tissue as seen in arthritis, atherosclerosis and cardiomyopathy.
  • MMP-9 increases lipoprotein a and oxidized LDL
  • MMP-9 correlates with high toxic load, total cytokine load, reflect disease progression, exposure, Herxheimer reaction (with TNF). It is a great marker for hidden cytokine production.
  • Increased in head injury
  • Patient may feel worse with CSM if they have high MMP9.

4. ACTH/Cortisol

Lab Results

Normal Range:

 ACTH:  8-37 pg./ml; 1.76-8.14 pmol/l

 Cortisol: A.M. 4.3-22.4 ug/dl; 3.07-15.99 umol/l

                        P.M. 3.1-16.7 ug/dl; 2.21-11.92 umol/l

Absolute or relative ACTH dysregulations may be seen:

  1. Absolute high: ACTH > 45 or cortisol > 21
  2. Absolute low: ACTH <5 or cortisol <4
  3. Relative:  ACTH was < 10 when cortisol was < 7- two-tiered test
  4. Relative: ACTH was > 15 when cortisol was > 16 –  two-tiered test
  • ACTH and cortisol are hypothalamic-pituitary-end organ dysregulation markers.  ACTH and cortisol measure hypothalamic regulation of the adrenal glands. ACTH is released with the breakdown of POMC. It stimulates the adrenals to release cortisol, a stress hormone.
  • Cortisol release raises blood sugar. Levels are higher in the morning and lower at night. Cortisol levels begin to increase at approx. 6 am in an individual with normal circadian rhythms (i.e. not a shift worker).
  • Cortisol is said to “boot us up – mentally and physically” in the morning.  If higher during the night, this may result in insomnia.
  • When stressed either physiologically or mentally, both cortisol and DHEA rise in tandem. We may adjust to long term stress with higher than average levels of both DHEA and cortisol. However, over time, levels of DHEA may start to decline, followed by cortisol levels. We may also have dysregulated day and night levels of cortisol with low daytime and high night time levels. Daytime fatigue and nighttime insomnia with awakening issues can result. 
  • The normal response of ACTH to cortisol is that if cortisol levels fall, ACTH levels should rise.
  • Both of these may be elevated in the beginning stages of CIRS but later both may be decreased.
  • Having low ACTH in relationship to cortisol is often a common pattern seen in CIRS.
  • Cortisol regulation is lost in 50 % of people with low MSH
  • Early in the CIRS diagnosis, as MSH falls, high ACTH is not associated with many symptoms
  • As ACTH falls, there is a marked rise in symptoms
  • People who are quite ill can have low ACTH and low cortisol levels.  
  • Treating CIRS through the different stages may correct these abnormalities.
  • Adrenal support through lifestyle and/or supplementation may also be needed. This approach, however, is not part of the Shoemaker protocol.

5. Antidiuretic Hormone (ADH) and Osmolality

Lab Results

Normal range:  ADH: 1- 13.3 pg./ml; 0.9 – 12.28pmol/l;

                           Osmolality: 280-300 mOsm/kg.

High serum osmolality – High ADH = normal

Low serum osmolality – Low ADH = normal

High serum osmolality with low ADH = abnormal. Consider treatment with Desmopressin

Absolute or relative ADH dysregulations may be seen:

  1. Absolute high: ADH > 13 or osmolality > 300
  2. Absolute low: ADH <5 or osmolality <275
  3. Relative:  ADH was < 2.2 when osmolality was 292-300 –  two-tiered test
  4. Relative: ADH was > 4 when osmolality was 275-278 –  two-tiered test
  • ADH and osmolality are hypothalamic-pituitary-end organ dysregulation markers
  • Dr. Shoemaker published data showing that up to 80 % of patients with CIRS have dysregulated ADH/osmolality levels.
  • If mold is remediated, biotoxins are bound with CSM, the VCS improves and MARCoNS is eradicated, low ADH will normalize in many cases on its own. Some patients will still require treatment.
  • ADH is a marker of disrupted MSH function. Reduced hypothalamic output of ADH in response to increased osmolarity is associated with reduced VEGF production in response to low microcirculatory oxygen levels. Low ADH is also associated with autistic behaviour and social avoidance behaviour in CIRS patients. [1] [2] 
  • The hypothalamus contains cells called osmoreceptors that respond to serum osmolality.
  • When the serum osmolality is high (body fluids/blood concentrated due to dehydration), the osmoreceptors shrink and release antidiuretic hormone from the posterior pituitary where it is stored. ADH is a 9-amino acid peptide. ADH binds to receptors on cells in the collecting ducts in the kidneys and reabsorbs water. Thus, cells become rehydrated and ADH levels fall.
  • When serum osmolality falls (overhydrated, more water in the blood), the osmoreceptors swell and block ADH release from the posterior pituitary. ADH levels drop and free water is lost in the kidneys.
  • In CIRS patients there is a dysregulation of this mechanism. Most commonly ADH levels are low (they may however be high) and osmolality levels are high (dehydrated); however, they may be low). What is apparent is that the ADH levels and the osmolality levels do not appear to be synchronous with each other as they should be in a healthy non-CIRS patient.

[1] Berndston K. Chronic Inflammatory Response Syndrome pg.  15

[2] Tansey KE, Hill MJ, Cochrane LE, Gill M, et al. Functionality of promotor microsatellites of arginine vasopressor 1A (AVPR1A): implications for autism. Molecular Autism. 2011 Mar 31;2(1):3

  • Patients with CIRS often have increased thirst and increased urination. They are also susceptible to electric shocks from touching door handles. This happening is due to the fact that as salt levels rise in blood due to the dehydration, salt is released onto the skin, through the sweat glands and creates a battery-like effect that increases the electrostatic shock potential. Chloride levels may be higher than cystic fibrosis patients in some cases.
  • Dehydration may also produce migraine like headaches.[1]
  • ADH also affects VIP and MSH levels in the suprachiasmatic nucleus of the hypothalamus. Without these three hormones, the hypothalamic regulation is significantly affected. Patients with low MSH will most often have low levels of ADH.
  • Treatment is to use DDAVP.

[1] Shoemaker R. Biotoxin Illness Treatment Protocol pg. 6

6. Melanocyte Stimulating Hormone (MSH)

Lab Results

Normal Range:  35-81 pg/ml; 206-478.7 pmol/. Run through LabCorp:

  • MSH is one of the most critically supressed neuroregulatory peptide hormones in the dysregulation seen in CIRS patients.
  • MSH is decreased in more than 95 % of patients with CIRS.
  • One of most potent anti-inflammatory compounds in the body; it regulates the innate immune system.
  • Inflammatory cytokines bind to leptin receptors, usually activating MSH and beta endorphins.  MSH would then control leptin. In biotoxin illness, cytokines block leptin receptors, MSH is not made, disrupting nerves, hormones and immune function.
  • MSH is controlled by leptin in the pituitary gland; pro-opiomelanocortin (POMC) is split into three components- alpha-MSH, or adrenocorticotrophin (ACTH) and beta-endorphin. 
  • MSH functions include: melatonin production, immune surveillance of mucous membranes intestinal permeability, nasal pathogen protection), regulates ADH and VIP, reduces inflammation, controls cytokine release in skin and gut, prevents Candida infections, controls pain through endorphin release
  • When abnormal, the result is problems with sleep, pain, gut symptoms, fluid dysregulation due to ADH with increased thirst and increased urination, cortisol dysregulation, fatigue, nasal colonization with MARCoNS, stress management problems, reduced sex hormones.
  • Due to leptin issues, weight gain which does not respond to more exercise and less eating, can be a problem.
  • Low MSH causes dysregulation of T reg cells leading to inflammation and autoimmune disorders
  • MSH has been shown to regulate the inflammatory cytokines (TNF and nitric oxide) found in inflammatory bowel disease.[1]
  • Low MSH associated with anti-gliadin positivity.

Important: Markers of hypothalamic illness include high leptin and osmolality, low MSH, low ADH, ACTH and/or VIP.


[1] Rajora N, alpha MSH Modulates Inflammatory Bowel Disease Peptides Vol 18 Issue 3 pg. 381-385.

TIER THREE CRITERIA

These criteria were based on the 2010 Consensus Report as written by Dr Shoemaker and his research committee. [1]  These criteria are evaluated after treatment has begun and are the final validation of the diagnosis of CIRS.

Improvement in the following areas is required to validate the CIRS diagnosis.

  1. Symptoms and VCS improve with treatment; and
  2. Lab markers (leptin, MMP 9) return to normal levels.

[1] Shoemaker RC, Mark L and McMahon S, Research Committee Report on Diagnosis and Treatment of Chronic Inflammatory Response Syndrome Caused by Exposure to the Interior Environment of Water-Damaged Buildings. Mold Research Committee, Pocomoke 2010

SUMMARY OF THE THREE TIERS CRITERIA FOR DIAGNOSIS OF CIRS:

  • Thus, in summary, with these Shoemaker criteria in mind, three of the Tier-Two criteria in addition to all of the Tier- One criteria must be met to make the preliminary diagnosis of CIRS.
  • Once the diagnosis is made, there are other proteomic, genomic and imaging studies which can be done in order to establish the diagnosis and assist in the treatment protocol.
  • One of the most striking features of the CIRS diagnosis is the absence of the anti-inflammatory neuropeptides vasoactive intestinal peptide (VIP) and melanocyte stimulating hormone (MSH), with the concurrent master immune regulator TGF beta-1 being abnormally increased.[1]
  • Patients should present with at least four out of the eight objective serum markers found in CIRS – TGFB1, VIP, MSH, MMP9, C4a, VEGF, ACTH/cortisol and ADH/osmolality.

[1] Shoemaker R.C. Ryan JC Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health 5 (3), 396-401

Government Accountability Office (GAO) 2008 Case Definition

The GAO issued its case definition in 2008 which became the standard for case definition. The GAO definition focuses exclusively on CIRS from water-damaged buildings and not from other initiating triggers. 

  1. Patient exposed to WDB -verified by presence of musty smells, visible mold or mycological testing.
  2. Multiple symptoms from multiple systems similar to Dr Shoemakers published research.
  3. Lab abnormalities similar to Dr Shoemaker’s lab abnormalities.
  4. Improvement with therapy similar to those found in peer-reviewed published research.

Challenges with CIRS Case Definition

One of the challenges of the CIRS case definition is that it takes more than one visit to confirm the diagnosis, patients need to have labs, need to take their medications, and thus the diagnosis cannot be made on the first visit.

Further Diagnostic Tests

If a patient has a positive exposure history, more than 6 symptom clusters, a positive VCS test, and fulfills the diagnositc criteria of the first 2 tiers, then further confirmatory lab testing must be done to confirm or diprove the CIRS diagnosis.

The following chart gives a visual representation of the biotoxin pathway with some of the lab markers being represented.

Biotoxin pathway

FURTHER BIOMARKERS/IMAGING/TESTS ASSESSED IN CIRS:

  • ERMI            
  • MARCoNS
  • Antigliadin antibodies
  • Androgens
  • Leptin
  • C3a
  • C4a- run through Quest
  • VEGF
  • TGFbeta-1
  • VIP
  • Von Willebrands
  • CD4+CD25+
  • Anti-cardiolipin antibodies
  • PAI-1
  • Pulmonary Function Tests
  • VO2 Max
  • Stress Echocardiogram
  • Neuroquant
  • Genomics

PHYSICIAN ORDER SHEET

Physician order sheet
Physician order sheet

ENVIRONMENTAL RELATIVE MOLDINESS INDEX (ERMI)

  • If water damaged buildings/mold is suspected, an ERMI is essential.
  • Mold illness and CIRS arise from any indoor environment that is damaged by water intrusion. Until recently, there had been no standardized objective methods available to quantify the indoor air mold burden.[1]  Air sampling has come under much criticism due to the fact that it samples air for just a few minutes in time, does not separate all the toxigenic molds into the correct genera, and does not take into account Wallemia. Stachybotrys can often be missed as it is not an airborne mold, being heavy in nature and existing mostly on the ground. Not all molds are toxic to humans and not all “mold is mold.”
  • Dr. Stephen Vesper and his team at the Microbial Exposure Laboratories of the EPA in Cincinnati pioneered the use of Mold Specific Quantitative Polymerase Chain Reaction (MSQPCR), and its application called the Environmental Relative Mold Index (ERMI).[2]  ERMI is an objective, standardized DNA-based method that will identify and quantify molds. ERMI does not measure the DNA of all fungi, but those that carry the highest implications for the relative mold burden in water damaged buildings.
  • There are currently three labs that offer the ERMI test: EMSL Analytical www.emsl.com, Mycometrics www.mycometrics.com and EMLab P&K www.emlab.com. Mycometrics is the most accurate according to Dr Shoemaker and provides both a Swiffer cloth method of detection and offers the HERTSMI-2 score. 
  • The ERMI classifies 36 species of mold into 26 species or clusters associated with WDB (Group 1) and 10 common species/clusters not associated with WDB (Group 2) and commonly found outside.[3]  The number calculated as the ERMI is the sum of the logs of the concentrations of the DNA of the different species. The mold index (ERMI) is the difference between Group 1 and Group 2. The ERMI was calibrated to the specific measurements (3 feet by 6 feet) in the living room and bedroom for 5 minutes and all the national standards reflect measurements from these areas only. Measuring mold in the basement only is not recommended as a first line measurement for these reasons. 

Computerized ERMI values are graphed from the lowest to the highest (see figure below). The ERMI value is typically between -10 (lowest mold levels) and 20 (highest relative mold levels). An


[1] Lin K-T, Shoemaker R.C. Inside Air Quality Filtration News Vol 26, No 3, pg. 32, 2007.

[2] Ibid

[3] Ibid

ERMI above 5 is in the top 75 % of homes for relative mold burden. An ERMI of -4 and below is on the lowest 25 % of homes in the US. 

Mycometrics LLC Report

As Dr. Shoemaker and Dr. Lin point out, the ERMI is a mold index, not a health index.

  • If the ERMI is low and there are people living in the home with positive symptoms for CIRS, that is, exceeding the cut-off criteria, and/or failing the VCS test, the ERMI should be repeated in different areas of the house. An ERMI does not exclude the value of a thorough top to toe visual inspection by a mold indoor specialist.
  • If you are not ill, an ERMI will help determine if your home is safe for visitors who have the mold susceptible gene and who are known to have health effects from moldy buildings
  • If the ERMI is low and no one is ill, one’s sense of security increases. Doing an ERMI is very helpful before one considers buying a new home. 
  • Elevated ERMI test result have been shown to have a positive correlation with lab abnormalities associated with CIRS, symptoms of CIRS, neurotoxicological studies, measurements of abnormal brain metabolites and symptoms of cognitive decline including brain fog, memory deficits and poor executive cognitive functioning. [1] Dr. Shoemaker writes that the high levels of mold translate in genetically susceptible patients into inflammation that reduces blood flow in particular parts of the brain so that it does not work efficiently. Furthermore, if a person is adequately treated but returns to a home with an ERMI above 2, he relapses.
  • In general, an ERMI value greater than 2 is considered unsafe for CIRS patients if the MSH is less than 35 and the C4a is less than 20,000. If the MSH is less than 35 and C4a is greater than 20,000, the ERMI score needs to less than -1.

[1] Ibid

HEALTH EFFECTS ROSTER OF TYPE SPECIFIC FORMERS OF MYCOTOXINS AND INFLAMMAGENS – HERTSMI-2

  • A secondary result can be calculated called a HERTSMI-2. This scoring system is application of the DNA testing shown on ERMI test results.  The new roster is designed to help patients previously sickened by water-damaged buildings and genetically predisposed understand if a given building is safe for occupancy. The roster is based on the results of 738 ERMI consecutive test results with 592 that were over 2 and 146 under 2.
  • This uses values of five specific molds-  Aspergillus penicilloides, Aspergillus versicolor, Chaetomium globosum, Stachybotrys chartarum and Wallemia sebi – from group 1 on ERMI based on 2 criteria:
  • Representative of varied water saturations (60-80%; 80-90%; 90-100%); and
  • Relative risk for enrichment is WDB compared to non-WDB is at least 10.

               A specific scale is used to grade the counts of each of the five species as and added up. 

             10 points are awarded for:

  • Aspergillus penicilloides                >500 spore E/mg
  • Aspergillus versicolor                      >500 spore E/mg
  • Chaetomium globosum                 >125 spore E/mg
  • Stachybotrys chartarum                >125 spore E/mg
  • Wallemia sebi                                    >2500 spore E/mg

             6 points are awarded for    

  • A. penicilloides or A. versicolor   >100
  • Chaetomium or Stachybotrys     >25
  • Wallemia                                             >500

              4 points awarded for   

  • A. penicilloides or A versicolor    >10
  • Chaetomium or Stachybotrys     >5
  • Wallemia   sebi                                  >100

*Any score over 15 is too dangerous for previously sickened patients to occupy.
*Any score under 11 has been safe to date.

* Some individuals may need a HERTSMI-2 score of <8 to not relapse

*Any score 11-15 is borderline. The building must be treated before safety can be assessed. 

Fungal ID/Sample IDSpore E./mg
Aspergillus flavus/oryzaeND
Aspergillus fumigatusND
Aspergillus nigerND
Aspergillus ochraceus<1
Aspergillus penicillioides13
Aspergillus restrictus*<1
Aspergillus sclerotiorumND
Aspergillus sydowiiND
Aspergillus unguis<1
Aspergillus versicolor190
Aureobasidium pullulans140
Chaetomium globosumND
Cladosporium sphaerospermum<1
Eurotium (Asp.) amstelodami9
Paecilomyces variotii<1
Penicillium brevicompactum45
Penicillium corylophilum1
Penicillium crustosum*10
Penicillium purpurogenum<1
Penicillium spinulosum*ND
Penicillium variabile<1
Scopulariopsis brevicaulis/fuscaND
Scopulariopsis chartarum13
Stachybotrys chartarum<1
Trichoderma viride*<1
Wallemia sebi230
Sum of the Logs (Group I):12.61
Acremonium strictum1
Alternaria alternata19
Aspergillus ustusND
Cladosporium cladosporioides 1130
Cladosporium cladosporioides 26
Cladosporium herbarum 63510
Epicoccum nigrum93
Mucor amphibiorum*1
Penicillium chrysogenum26
Rhizopus stolonifer<1
Sum of the Logs (Group II):10.26
ERMI (Group I – Group II):2.35

MULTIPLE ANTIBIOTIC RESISTANCE COAGULASE-NEGATIVE STAPH (MARCoNS)

Lab Test: API-Staph culture

Resistance to two or more distinct classes of antibiotics plus the presence of a biofilm.

  • MARCoNS plus biofilms is identified by a nasopharyngeal culture. Thrives in deep aerobic spaces of nasal cavity.
  • Must use API Staph Isolate to get biofilm forming coagulase negative Staph. This is not a routine nasal culture technique that is only cultured for two days at Quest or LabCorp.
  • Biofilms are slimy polysaccharide matrixes that surround the bacteria, acting as a protective barrier protecting bacteria from the immune system.
  • Dr Shoemaker observed in 1998 that in MSH deficient patients, over 80 % had MARCoNS in the nasopharynx and in MSH normal patients, less than 1 % were positive for MARCoNS. 
  • MARCoNS will result in MSH deficiency.
  • MARCoNS release endotoxin A and B which cleave MSH, rendering it ineffective and thus leading to immune dysregulation.
  • MARCoNS release hemolysins, which disrupt red blood cells and endothelial cell membranes increasing inflammation, coagulation risk, and anti-phospholipid abnormalities.
  •  Low MSH impairs its ability to coordinate dendritic cell responses within gut and respiratory mucous membrane compartments. [1]
  • With low MSH, multiple neuro-immune pathways are impacted leading to dysregulation in ACTH, cortisol, androgens, ADH and osmolality, melatonin (sleep disturbances), endorphins (pain issues.)   In addition, cytokines are stimulated.
  • MSH acts as a guard immune modulator on the skin and mucous membranes and kills fungi and coagulase negative staphylococci. With normal MSH, MARCoNS will not survive. [2]
  • Inadequate treatment of MARCoNS will reduce the efficiency of CSM therapy possibly because of MARCoNS continued effect on MSH.
  • Low MSH patients rarely get better until MARCoNS is treated. Hard to raise MSH with MARCoNS present.
  • With MARCoNS, thick biofilms are made which prevent antibiotics and natural immune function from dealing with the offending organisms.
  • MARCoNS colonization produces no symptoms but dysregulates MSH.
  • MARCoNS can also be isolated from dental cavitations.
  • MARCoNS with low MSH patients have a differential genomic profile than negative MARCoNS patients and low MSH. [3]
  • MARCoNS not to be confused with other coagulase -negative staphylococci that are not antibiotic resistant.

[1] Catania A, Caterina L, Sordi A, et al., The melanocortin system in control of inflammation. The Scientific World Journal 2010; 10:1840-1853.

[2] Shoemaker R. Katz BEG DVD 2013

[3] Shoemaker R. Katz 2013 BEG DVD

Microbiology Dx report
Microbiology Dx report

ANTIGLIADIN- ANTIBODIES (AGA)

Lab results

AGA normal range:  0-19 U

  • Low MSH results in T reg dysregulation, leading to inflammation and possibly autoimmunity
  • Serum IgA and IgG antigliadin antibodies (AGA) are antibodies against gliadin, the protein found in wheat, barley and rye. Some oats is cross-contaminated with gliadin but does not, in and of itself, contain gliadin.
  • AGA is not specific for celiac disease, but it does indicate an inflammatory response to gluten
  • I tend to do the HLA DQ2/DQ8 genes and serum tissue transglutaminase (TTG-IGA) levels to exclude celiac disease.
  • Over 58 % of children with CIRS have elevated AGA levels according to Dr. Shoemaker.

ANDROGEN DEFICIENCY

Lab Results

Normal Range:  DHEA and testosterone: Various ranges for age and gender

  • Abnormal androgens are due to an upregulated aromatase enzyme.
  • Testosterone is often dysregulated and DHEA may be low.
  • Using testosterone is contraindicated in these patients.
  • Due to low VIP and inflammation, testosterone is more rapidly converted into estrogen resulting in high estrogen and low testosterone.
  • One may use DHEA.
  • VIP nasal spray corrects aromatase activity.

LEPTIN

Lab results: LabCorp

Normal ranges: 0.5-13.8 ng/ml; in men

                            1.1-27.7 ng/ml; in women

  • Leptin is a hormone that controls how fat stores fatty acids. If the leptin receptors are disrupted, high levels of leptin will be seen.
  • Leptin regulates the pro-opiomelanocortin (POMC) pathway, thus MSH pathways that also control ADH.
  • Low leptin levels contribute to low MSH, ADH, VIP and ACTH.
  • Leptin outside the brain binds to immune cells and increases inflammatory cytokines. [1]
  • If leptin is high, fatty acids are stored in fat, resulting in weight gain.
  • Leptin is not considered a major marker in the CIRS workup.  
  • Markers of hypothalamic illness include high leptin and osmolality, low MSH, low ADH, ACTH and/or VIP.

[1] Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and periphery. Recent Progress in Hormone Research. 2004; 59: 305-31. PMID: 14749508

C3a

Lab results: Quest

Normal ranges: 55-486 ng/ml;  

  • C3a generated when C4a and C2a are made by activating MASP-2; splitting C4 and C2 creates C4b and C2a thereby activating C3
  • C3a is only activated when the innate immune system is presented with a bacterial cell membrane.
  • If elevated, tick -borne illness must be excluded or diagnosed.
  • Increased C3a can cause anaphylaxis through an upregulated immune response resulting in vasoconstriction, capillary hypoperfusion, increased vascular permeability and WBC release of oxidants, leukotrienes and enzymes.[1]
  • C3a will usually be low unless there is Lyme- usually more acute in nature.
  • C3a elevates within 12 hours of a tick-bite
  • If HLA is Lyme susceptible pattern – 15-6-51; 16-5-51, most likely will need longer than 3 weeks of antibiotics and CIRS can be a distinct possibility.
  • Will need Cholestyramine to remove the biotoxins if inflammatory CIRS markers and positive VCS present.
  • May need statin therapy if C3a persists after antibiotic therapy.

[1] Shoemaker R Biotoxin Illness Treatment Protocol pg. 8

C4a

Lab Results: Quest

Normal Range:  0-2830 ng/ml;

  • If levels are very high, this could be due to delays in shipping, sample not frozen quickly enough or the specimen thawed in transit.
  • C4a is an innate immune system biomarker. If high, it usually means that the innate immune system is in overdrive to PAMPS (pathogen -associated molecular patterns) and that a biotoxin burden is present.
  • Usually results in capillary hypoperfusion of the CNS.
  • C4a is a split product of the mannose binding lectin pathways of the complement system of the innate immune system and predicts the severity of CIRS.
  • C4a has been associated with elevated levels of mannin-binding lectin serine protease 2 (MASP2) in patients with chronic fatigue syndrome.[1]
  • C4a helps the antibodies and phagocytic cells remove infections and toxins from the body.

[1] Sorensen B, Jones JF, Vernon SD, Rajeevan MS. Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Molecular Medicine 2009 Jan-Feb; 15 (1-2): 34-42

  • Complement proteins circulate as inactive precursors but when split into active components they amplify the immune response of the membrane attack complex (MAC).[1] MAC kills the outer layer of cells causing cell death.
  • Both C3a and C4a are anaphylatoxins which cause smooth muscle release, can activate mast cells, increase histamine, increase basophils, increase vascular permeability, cause capillary hypoperfusion with resultant cellular hypoxia resulting in reduced mitochondrial function, increase lactate production from glycolysis,  and can increase cognitive dysfunction (memory loss, concentration, word finding difficulties, disorientation, confusion, difficulty integrating new information.) as well as fatigue. [2]
  • Brain fog caused by increased lactate and suppression of the glutamate/glutamine ratio. -increased inhibition versus excitation.
    • When C4a with anaphylatoxin activity stimulates the degranulation of mast cells, vascular permeability ensues, dermatographia can exist on the skin and smooth muscle contractions occur.
    • C4a can causes high lactate levels >1.29 and low glutamate/glutamine ratio <2.19 on MR spectroscopy.
    • If C4a levels are above 20,000 with low MSH levels the individual cannot be in a home with an ERMI above -1.
    • Cognitive functions improve when C4a drops.
    • C4a can be elevated in Lyme disease and SLE.

[1] Rapaport S. Evaluation and Treatment of CIRS pg. 7

[2] Ogata RT, Rosa PA, Zepf NE. Sequence of the gene for murine complement component C4a. The Journal of Biological Chemistry, 1989; 264( 28): 16565-72.

VEGF

Lab results: LabCorp and Quest

Normal Ranges: 31-86 pg./ml

  • VEGF is a marker of capillary hypoperfusion. A low level of skeletal muscle VEGF is associated with decreased muscle endurance.[1]
  • Treat VEGF if less than 31. If high, say 105, it means the innate immune is activated, but does not give the cause.
  • VEGF is high in renal failure and Bartonella infections. [2]
  • Inflammatory cytokines bind to endothelial receptors, which release “glues”- adhesion and integrins.  These hold the white cells together and narrow the capillaries creating hypoxia. This is sensed by regulatory cells which produce a gene controller hypoxia inducible factor (HIF), which produces VEGF.  
  • VEGF is a growth factor which stimulates blood vessel growth in response to HIF and dilates blood vessels in healthy people.

[1] Olfert IM, Howlett RA, Tang K, Dalton ND et al. Muscle specific VEGF deficiency greatly reduces exercise endurance in mice. Journal of Physiology 2009 Apr 15; 587:1755-1767

[2] Kempf VAVolkmann BSchaller MSander CAAlitalo KRiess TAutenrieth IB. Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol. 2001 Sep;3(9):623-32.

  • In biotoxin patients, inflammation and cytokines suppress VEGF, creating persistent capillary hypoperfusion.
  • This result in fatigue, cognitive fallout, muscle aching, and poor recovery from exercise due to anaerobic mitochondrial metabolism.
  • Usually glycolysis and protein are used for energy, taking several days to replenish glycogen.
  • In lactic acid metabolism, due to low VEGF, one obtains only 2 ATP for every glucose molecule, instead of 36 ATP as is normally the case.
  • Early in CIRS, VEGF can be increased, signifying that the body is trying to compensate for low oxygen delivery to tissues.

TRANSFORMING GROWTH FACTOR BETA-1 (TGF beta-1)

Lab results: LabCorp and Quest

Must be double spun plasma with Cambridge to make sure all plasma platelet contamination is gone. Not serum. If result is greater than 40,000, the specimen is likely mishandled.

Normal range:   < 2380 pg/ml; =normal

> 5000 = symptoms appear

                                > 10,000 = restrictive lung disease, tremor, cognitive issues, joint problems may occur

  • TGF beta-1 is a protein that causes cells to change and usually results in innate-adaptive immune system dysregulation. It can either produce or suppress inflammation.
  • It must be addressed vigorously as it represents widespread tissue involvement, most common in people with highly susceptible 11-3-52B and 4-3-53 HLA haplotypes. Limiting mold exposure is crucial to down regulate this biomarker.
  • Elevated levels usually indicate that the body is trying hard to down regulate an overactive T cell adaptive immune system as in allergy (asthma) and autoimmunity (multiple sclerosis) as well as an overactive innate system (CIRS)- both caused by biotoxins in the HLA susceptible host.
  • TGF-beta-1 has a dual function in the innate immune system. If elevated it indicates an overactive immune system and it a key marker of the CIRS severity.
  • If stays high, it can indicate the person is having a difficult time recovering.
  • It helps control the growth and differentiation of cells, cell motility and cell death. In utero, it helps form new blood vessels, regulates muscle and body fat development and wound healing. 
  • It is an inflammatory regulatory cytokine which affects autoimmunity through differential gene activation. It can damage T reg cells CD4+CD2++, which regulate TH1 (autoimmunity), TH2 (allergy), TH17 cells. It converts CD4+CD25++ T reg cells into pathologic T cells, thus activating TH17 (autoimmune system) driven inflammation. Together, TH-17 and T-regulatory cells are responsible for preventing autoimmunity. TGF beta-1 can thus activate or reduce autoimmunity.
  • In the treatment, one must increase the low T reg cells (cellular immunity) and lower TGFB, thus improving humoral immunity.
  • If T reg cells are low <4.66 %, TGF beta will be high > 2,380.
  • VIP will raise T Reg cells (CD4, CD25).
  • TGF beta-1 can cause tissue remodeling in the liver, heart, central nervous system and the kidney.
  • If TGF beta-1 levels are >10,000, this may result in pulmonary remodeling and interstitial, restrictive lung disease (shortness of breath and asthma like symptoms), pulmonary
  • hypertension (where endothelial cells become thick fibroblasts and result in acquired pulmonary hypertension). Pulmonary stress testing can determine VO2 max and pulmonary function testing can look for signs of restrictive lung disease. Stress echocardiogram to estimate pulmonary arterial pressure (the measurement of the tricuspid jet and right atrial pressure) can also be done and which will measure further pulmonary cell transformation
  • High TGF beta-1 associated with joint inflammation
  • High TGF-B-1 may result in neurological diseases (MS), seizures, tremor, Parkinson’s, Autoimmune diseases (lupus, RA, dermatomyositis, ulcerative colitis, positive ANCA, ACLA, scleroderma), learning disabilities, vocal polyps and nasal polyps  and cognitive symptoms.
  • High TGF beta-1 can be seen in HIV, cancer and connective tissue disorders
  • High TGF beta-1, along with low MSH can contribute to GI dysfunction which improves when immune markers are normalized.
  • CD4+CD25++ blood levels = T reg cells. If low, the TGFbeta-1 would expect to be high.
  • VIP will cause T reg cells to increase, but re-exposure to biotoxins will cause them to drop.
  • TGF beta-2 will cause hair loss with increased catagen hair. Growing hair follicles are anagen, rest-phase hair is telogen but dying hair follicles are catagen due to TGF β-1.[1]

[1]Hibino T1Nishiyama T. Role of TGF-beta2 in the human hair cycle  J Dermatol Sci. 2004 Jun;35(1):9-18.

VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)

Lab Results: Quest

Normal range:   23-63 pg/ml

  • No accurate test for VIP at the moment.
  • VIP is a 28-amino acid regulatory neuropeptide, neuro-immune modulator which downregulates cytokine levels with interactions with other peptides: MSH and Vasopressin.
  • It has hypothalamic receptors; it regulates blood flow and distribution.
  • Low levels are associated with capillary hypoperfusion and abnormal pulmonary artery pressure at rest or in response to exercise. [1]
  • It is also made in the nerve endings, gut and pancreas.
  • It can have a positive effect on the entire Biotoxin Pathway.
  • Like MSH, it regulates peripheral cytokine responses and inflammation throughout the body.
  • Low levels found in 98 % of CIRS patients and in less than 10 % of controls.
  • VIP helps reduce pulmonary artery hypertension. If pulmonary artery pressure raised with tricuspid valve regurgitation, one can have shortness of breath, especially with exercise. VIP will help reduce post exertional fatigue and shortness of breath
  • Helps with MCS, releases endorphins, reduces sicker-quicker phenomenon, downregulates MASP2- the enzyme that stimulates cleavage of C4-C4a; the key to reducing “quicker/sicker” phenomenon.
  • VIP induces smooth muscle relaxation in the intestinal tract stimulating water secretion into bile and pancreatic fluid; it can reduce stomach acid and absorption of nutrients from the GI tract. Diarrhea can result.  

[1] Berndtson K. Chronic Inflammatory Response Syndrome. Overview, Diagnosis, and Treatment. Pg.7

  • Restores hormone levels, Vit D 3 levels, decreases aromatase upregulation caused by cytokines thereby restoring estrogen and testosterone levels, corrects ADH/osmolality.
  • Helps restore energy in chronically fatigued patients.
  • Enhances IL-10 production
  • Increases CD4+/CD25+ T reg cells, restoring their numbers and thereby regulated TH 17 autoimmune response. If used appropriately, it will suppress overly active inflammation and will regulate dendritic cells, the cells that mediate between the innate and adaptive immune systems.  Inhibits TGF beta-1. Down regulates cytokines and thus is a down-regulator of inflammation
  • Restores circadian rhythm.
  • It helps treat genomic dysregulation caused by CIRS.
  • VIP assists in treating the brain abnormalities found in NeuroQuant esp. caudate nuclei atrophy.
  • Upregulates VEGF esp. if not responded to Actos or Fish oil 1 spray – alternating nostrils 4 times per day.
  • Dr. Shoemaker published a study in 2013 on VIP used on CIRS-WDB patients which demonstrated the following: [1]
    • refractory symptoms reduced to control levels
    • corrected inflammatory biomarkers -C4a, TGF beta-1, VEGF and MMP 9 and reduced levels to controls
    • raised VIP and MSH, corrected estradiol, testosterone and Vit D levels,
    • corrected T-reg levels,
    • retuned PASP during exercise to normal
    • enhanced quality of life in 100% of patients in the study
  • Dr. Shoemaker found that 100 % of over 500 patients with multiple chemical sensitivities were found to have low VIP.
  • In order to use VIP, need to be out of a moldy building (ERMI less than 2), have a normal VCS and be MARCoNS free.

[1] Shoemaker RC, House D, Ryan J. Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings. Health, 2013; 5 (3) 396-401

CD4+ CD25+

  • No commercial test is currently availablealthough select centres may do the test under special circumstances. 

VON WILLEBRANDS PROFILE

Lab results: Quest

  • Factor VIII activity, von Willebrand Factor antigen, Ristocetin Cofactor, von Willebrand Factor Collagen Binding Assay, von Willebrand Antigen) –as well as coagulase study- PT, PTT, PT/INR –  esp. if history of bleeding with exposure to WDB.
  • Patients with levels of Factor VIII, von Willebrand’ s antigen or Ristocetin associated cofactor either <50 or >150 IU are classified as abnormal for von Willebrand’ s antigen.
  • Blood will be thinner and bleeding will result.
  • Acquired von Willebrand syndrome can be the result of increased C4a resulting in increased bleeding tendencies. Water damaged building avoidance is the first step in treatment as well as using DDAVP.

ANTI-CARDIOLIPIN ANTIBODIES

  • Marker of autoimmunity.

PAI-1

  • A marker of increased blood coagulation.

PULMONARY FUNCTION TESTS

Unusual shortness of breath with post exertional fatigue warrants a workup for pulmonary function and possibly acquired pulmonary hypertension.

  • In CIRS, pulmonary function tests may show a restrictive pattern rather than an obstructive pattern of respiratory difficulties. If restrictive test is shown, proceed to VO2 max.  

VO2 MAX

  • VO2 max testing done on a treadmill may show abnormally low VO2 max, often lower than 20. This reflects capillary hypoperfusion and post exertional fatigue and malaise. High cytokine levels can first raise and then lower VEGF leading to chronic tissue hypoxia. CIRS patients have a lower threshold for hypoxia as a result.
  • Exercise is very helpful for these patients but they must stay below their anaerobic threshold.  If they stay below their anaerobic threshold, glycogen store depletion is prevented. This is determined by performing a cardiopulmonary stress treadmill test.
  • VO2 max > 35 = normal
  • VO2 max < 20 = CIRS patients 
  • VO2 max 12-15 = Stage IV Cardiac failure

STRESS ECHOCARDIOGRAM

This is to be pursued in the patient with unusual shortness of breath, asthma like symptoms and excessive post-exertional fatigue/poor exercise tolerance.

  • A stress echocardiogram will non-invasively measure the tricuspid jet and the right atrial pressure, thus estimating pulmonary arterial pressure (PA) response to exercise.
  • Normally the pulmonary pressure drops with exercise, allowing for increased oxygenation.
  • In CIRS patients, the PA pressure may increase, resulting in reduced oxygen absorbed into blood during exercise and thus poor exercise tolerance
  • A high pressure at rest may be seen, esp. if TGF beta-1 is high and T-reg cells are low. Th-17, induced by high TGF beta-1 will convert T reg cells to pathogenic T cells.
  • Avoid mold, use losartan and use VIP to correct this abnormality.

NEUROQUANT

A Neuroquant MRI is a software addition to an MRI and assists in determining if there are any changes in brain volume and structure according to specific quantifiable determinants in 11 different brain regions.

 Patients with CIRS due to mold exposure have a specific pattern of abnormalities as compared to controls:[1]

  • Forebrain parenchyma increased
  • Cortical gray increased

[1] Shoemaker R, D House R, Ryan J, Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings,” Center for Research on Biotoxin Associated Illness, Pocomoke

  • Hippocampus increased – although not included in the criteria
  • Caudate decreased – reversible through use of VIP according to Dr. Shoemaker’s clinical experience
  • Pallidum increased

Patients with CIRS due to Lyme neuroborreliosis have the following pattern:[1]

  • Small forebrain parenchyma
  • Small putamen
  • Large thalamus – (isolated post gray matter change)
  • Large cerebellum

Neuroquant also assists in the detection of other nuclei that can be atrophied and is helpful when looking at brain atrophy in dementia Alzheimer’s disease.

In Dr. Shoemaker’s research, no confirmed case of CIRS had less than 5 points and no controls had 3 or more points. One needs to take the average of the two sides to determine the points awarded.


[1] Ibid

 Black = Mold  Red = Lyme1 point2 points
Forebrain>31.9>32.5
Cortical Gray>16.3>17.0
Caudate<0.255<0.235
Pallidum>0.07>0.08
Putamen<0.345<0.335
Right thalamus>0.58>0.60
 AtrophyHypertrophy
Forebrain<29.00>31.9
Cortical Gray<13.50>16.3
Hippocampus<0.255>0.31
Amygdala<0.10>0.14
Caudate<0.255>0.30
Putamen<0.345>0.375
Pallidum<0.055>0.07
Thalamus<0.495>0.58
Cerebellum<3.50>4.55

GENOMICS

www.survivingmold.com/store1/progene-dx

  • PAX genomics allows for measurement of mRNA and miRNA in serum samples so as to assess metabolic patterns of cellular function based on RNA transcription patterns. [1]

A 2016 paper by Dr Shoemaker and James Ryan set out the underlying genomic abnormalities found in white blood cells that can result in someone suffering from a CIRS diagnosis leading to


[1] Berndston K.

  • chronic inflammation. [1] 14 patients who had failed the normal CIRS protocol were investigated genomically while using VIP.
  • This new RNA sequencing focuses on the abnormal gene expression found in the white blood cells of CIRS patients. Several key immune regulators were found to be differentially expressed over the course of the investigation including CD244, CD3D, CD48, CD 52, granzymes, defensins, and the Ikaros family of lymphoid transcription factors.
  • Two families of genes upregulated in CIRS are alpha defensins (these are antimicrobial peptides which keep bacteria in bodies from spreading by using mucosal layer coating inside the gut, airways or nasal passages) and granzymes (these are cytotoxic proteases found elevated in patients with autoimmune disease and infections). [2] These were downregulated with VIP.
  • The Ikaros family of five different zinc finger transcription factors may indicate a decline in lymphocyte proliferation after treatment with VIP.
  • In addition to these down regulated innate immune functions, there was a significant metabolic shift with a downregulation of ribosomal and mitochondrial gene expression possibly indicating a quietening of the overall upregulated immune response. [3] 
  • Patient reporting of CIRS symptoms decreased from a mean of 12.9 to a 3.3 over the duration of the therapy. TGF beta-1 and C4a were significantly lower after VIP therapy. MMP9 was lower post VIP but not significantly and VEGF was unchanged.
  • In addition, ribosomal genes as well as nuclear encoded mitochondria genes were shown to be down regulated after treatment with VIP and this coincided with the abatement of symptoms.  This argues the return to normal function of ribosomal and mitochondrial gene expression.
  • It is a great advance in the treatment of CIRS that both pre- and post-genomic expression patterns can be measured. Added to the measurement of proteomic expression and Neuroquant evaluation pre- and post treatment, the genomic insights add much additional value to quantifying the patients return to normal functioning.
  • Diagrams per Jimmy Ryan presentation at 2016 Surviving Mold conference Irvine, California.

[1] Ryan J, Shoemaker RC, RNA-Seq on patients with chronic inflammatory response syndrome (CIRS) treated with vasoactive intestinal polypeptide (VIP)shows a shift in metabolic state and innate immune fluctuations that coincide with healing. Medical Research Archives Vol 4 Issue 7 2016.

[2] www.survivingmold.com

[3] Ibid.

Before VIP
After VIP
Mitochondrial proteins pre-vip
Mitochondrial proteins post-vip

OTHER LAB TESTS DONE IN CIRS

  • These lab tests are done to rule out other possible illnesses.
  • CBC, Metabolic panel, Lipid panel, C-reactive protein, ESR, ANA, ENA, Thyroid studies with thyroid antibodies, sex hormones (estradiol, progesterone), pregnenolone, cardiolipin antibodies, PTT, Prothrombin time, Thrombin time, d-Dimer, IgE, Immunoglobin panel, protein electrophoresis.
  • If autoimmunity is suspected, check anti-gliadin antibodies, (due to low MSH and dysregulation of T reg cells) anticardiolipin antibodies, lupus anticoagulant, phospholipid.
  • If mast cell activation syndrome is suspected, consider doing serum histamine, serum tryptase, urinary prostaglandin D2, enolase.

Treatment Steps

Stepwise treatment protocol for CIRS

Dr. Shoemaker’s Surviving Mold Protocol involves a number of specific steps:

It must be kept in mind that CIRS is an inflammatory upregulation of the innate immune system and is thus an immune disorder occurring in genetically susceptible individuals. It will not therefore just respond to removal of the initial triggers. The particular triggers do need to be taken into account, but so does the immune dysregulation, the inflammatory markers, the neurohormonal abnormalities, potential autoimmune dysregulation as well as possible coagulation disorders.  

  1. Removal from exposure – monitor home or WDB with ERMI or HERTS-MI-2 testing
  2. Removal of biotoxins with either cholestyramine or Welchol – monitor with VCS
  3. Treat MARCoNS with BEG spray or EDTA- Check API-Staph nasal culture
  4. Begin a gluten free diet if anti-gliadin antibodies present
  5. Correct abnormal androgens – use DHEA-S if indicated
  6. Correction of elevated MMP-9
  7. Correction of low VEGF
  8. Correction of elevated C3a
  9. Correction of elevated C4a
  10. Reduce elevated TGF-beta-1
  11. Treat low VIP
  12. Recheck labs and VCS

STEP 1: REMOVAL FROM EXPOSURE

  • This is the most important step in the treatment process if a diagnosis of CIRS has been established. Attempt to determine the source of the biotoxin exposure; was it from Borrelia spirochete, dinoflagellate food poisoning or ciguatera. A person may be exposed to one or more of these toxins. If the source is identified, every effort must be made to remove the individual from the source of exposure.
  • If water damaged building is the issue and as up to 50 % of all USA homes have some form of water damage, mold exposure and all the corresponding inflammagens are the most frequent source of biotoxin illness. An ERMI test must be done and a visual inspection must be undertaken by a qualified mold/indoor air specialist. The article Inside Indoor Air Quality by Dr. Ritchie Shoemaker and Dr.  King-Teh Lin is a helpful resource.
  • If an ERMI test is positive with a reading >2, the building or home is considered unsafe for occupation with the CIRS diagnosis.  
  • Once a building has been declared unfit for occupation due to the visual inspection and the patient fulfilling the CIRS diagnosis, a sick patient should most often have to be removed from the building and a mold remediation team is called in.
  • One of the challenges for CIRS patients is what to do with belongings as they often have to be removed (clothing, furniture that cannot be adequately wiped down, contents esp. paper and cloth products and personal effects). All porous material should be removed and taken out of the house and discarded. Non-porous items need to be thoroughly and professionally cleaned.
Diagram: Written permission granted by Dr Lynese Lawson
Diagram: Written permission granted by Dr Lynese Lawson
  • Finding someone who can adequately undertake the remediation is often a major problem. An organized approach to the problem is vital but often is not able to be initiated due to the cognitive difficulties many people face with the CIRS diagnosis.
  • Small brief exposures must be avoided due to “sicker, quicker” phenomenon.
  • Patients that I see are given a list of companies that can assist them in their assessment and remediation process. HEPA filters (IQ air and Blue Sense Air filters) are used which can remove particles smaller than 0.3 microns in size. Air purifiers such as the Air Oasis are also used.
  • It is important that remediation efforts are continued until ERMI levels are down to safe levels – ERMI less than 2 or = 2 in patients with MSH <35; ERMI to < or = to – 1 if MSH <35 and C4a >20,000 with HERTSMI-2 < 11.
  • Post remediation testing should occur 3-5 weeks after remediation. One can place black or green garbage bags and collect new dust.

STEP 2: REMOVE TOXINS AND INFLAMMAGENS

Biotoxins must be removed from the body, particularly in a patient with the genetic predisposition to biotoxin illness. These patients cannot recognize the biotoxins and need help in doing so.

Cholestyramine (CSM), a bile acid sequestrant, has a quaternary cation structure that binds negatively charged ionophore biotoxins which possess an anion dipole. The biotoxins are excreted in bile and removed from the body while bound to the CSM, through the GI tract. This excretion prevents enterohepatic recirculation of the biotoxins. A handout should be given and consent obtained.

CSM can also bind industrial chemicals

  • CSM must be taken on an empty stomach away from meals and medications and/or supplements. 
  • Many people start with ¼ teaspoon a day. Take ½ hour before meals and 1 hour after meals, drugs or supplements.
  • Drink 6 –  8 oz. of water with the dose.
  • Juice is often a better mix for this very chalky tasting medication.
  • Side effects include heartburn, GERD, belching, bloating, nausea, bad tastes and/or constipation.
  • Welchol is a second option, although not as effective. There is said to be a 4:1 differential in terms of efficiency for biotoxin removal. CSM has 4 times as many electrically active sites. However, Welchol may be better tolerated but longer to change lab tests in the right direction.
  • These two binding agents are to be taken until the patient either passes the VCS test and/or eradicate MARCoNS.
  • Some patients combine the two meds: CSM twice per day – morning and bedtime and Welchol – lunch and dinner. Avoid the CSM with aspartame additives.
  • Chemically sensitive patients and patients with GI issues and/or food allergies, do better on Welchol.
  • If problems with toxin release or treatment reactions, start with Actos 15-45mg a day, or EPA 2.4 gms DHA 1.8gms for 5 days, then add cholestyramine again.
  • If Leptin <7 use omega 3s.
  • Watch fat-soluble vitamins A, D, E, K as CSM can bind these.
  • Welchol 625- work up to 2 caps three times per day.
  • CSM dosing: 4 -9 grams four times a day. Mix with 6 oz. water or juice. 30 mins before food. Followed by 4-6 oz. water.  
  • Paed. <120 lbs. or less than 18 years old.  Use 60 mg/kg/dose TID with 6 oz. water 30 mins before food.
  • Use Welchol 625 bid (1 tab) if out and about and exposed to mold.
  •  If re-exposed- use Welchol or CSM for 3 days.
  •  Works within a week.
  • Treat constipation with magnesium oxide or citrate powders. Can use 70 % sorbitol (Miralax).
  • Recheck VCS one month after starting treatment and then with each step.
  • When VCS normalized, switch to Welchol 625 mg twice daily if person is out a lot.
  • If at home mostly, no meds used.
  • If treatment fails, consider continued exposure, non-compliance or MARCoNS not adequately treated.   

STEP 3: ERADICATE MARCoNS

If positive for MARCoNS on API-Staph culture and if associated with a biofilm, eradication is important.

BEG spray:

  • Start one month after using CSM
  • Comprised of Bactroban, EDTA, and Gentamycin.
  • Blow nose first.
  • Use for 30 days 2 sprays each nostril 3 times per day in adults, 1 spray alternative nostril in children- seldom need to use
  • The patient may feel worse after starting treatment due to “die-off”.
  • Use low amylose diet, high dose fish oil and Actos if this occurs.
  • Repeat nasal culture to see if eradicated.
  • If symptoms worse after starting, it may imply re-exposure; VCS row D and E will fall and MMP9 will go up
  • If still positive after treatment, consider pet dog as source of reservoir, re-exposure to mold, or a partner with low MSH and MARCoNS
  • Rifampin has been used in the past at 600 mg per day with adults or 10-20 mg/kg/day in children. Start the rifampin the same day as the BEG spray to discourage resistance
  • Rifampin is known to induce multiple enzymes responsible for drug metabolism including cytochrome P450 (CYP)1A2, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and some glucuronidation pathways. In addition, it has been reported to induce the activity of several drug transporters, such as the organic anion transporter and P-glycoprotein.[1] Need to quite careful with anticoagulants and pain medications (may reduce their efficiency).
  • Recent MARCoNS resistance to multiple antibiotics has emerged due to what Dr Shoemaker believes to be the overuse of -azole antifungals.
  • This step is essential if VIP is going to be successful.
  • If symptoms worsen after 1 month, check for re-exposure, recheck VCS and MMP9 levels.
  • If patient better, stop BEG spray, recheck API- Staph nasal culture and VCS.

[1] http://www.pharmacytimes.com/publications/issue/2011/april2011/druginteractions-0411

STEP 4: ELIMINATE GLUTEN IN AGA POSITIVE PATIENTS

  • If positive for AGA, it is imperative they are completely gluten free for at least 3 months.
  • This will reduce GI sources of inflammation
  • The no-amylose diet prescribed during CSM treatment is already gluten free, thus no gluten continues for an additional 3 months assuming that that the VCS corrected.
  • No amylose diet involves eliminating:
  • Grains- wheat, rice, barley, oats, rye – corn appears to be okay as has a natural inhibitor of amylase- no sugar added.  
  • Fruits-all fruit allowed except bananas. Can use fresh fruit juice.
  • Vegetables – all okay except root vegetables grown below the ground (potatoes, yams, radishes, carrots, beets). Garlic and onions are okay.
  • Other foods –  glucose, dextrose, sucrose, maltodextrin, low-fat corn syrup, cereal, chocolate, fast food, soft drinks, commercial fruit juices. Lactose (milk), artificial sweeteners, spices and condiments, diet soft drinks and caffeine drinks are allowed
  • Many patients will have many other possible food issues including but not limited to IgE allergies, IgG sensitivities, oxalate issues, salicylate issues, FODMAPS issues, SIBO issues, high histamine issues etc. These issues are not part of the Shoemaker protocol but need to be taken into account when addressing and treating chronic GI issues. 
  • If AGA is negative after 3 months, reintroduce gluten and keep monitoring for GI symptoms.
  • If patient feels better off gluten, and/or AGA returns as positive, stay off gluten for life.
  • If a patient is known to have celiac disease, it is imperative he follows a strict gluten free diet for life. [1]

[1] Shoemaker RC. Surviving Mold: Life in the Era of Dangerous Buildings. Otter Bay Books. Baltimore 2010.

STEP 5: CORRECT ANDROGENS: DHEA/Testosterone/Androgens and Cortisol

Treatment:

  • DHEA – 25 -75 mg a day- men. 5-25 mg a day -women
  • HCG injections 125 250 mg twice weekly. This raises LH. Not part of Shoemaker protocol
  • VIP nasal spray 4 times per day for 30 days- can stabilize aromatase and rebalance androgens
  • Measure DHEA before treatment and monitor estradiol levels- at least every 3 months
  • Resist using testosterone replacement
  • Do not use aromatase inhibitors with a low-MSH patient<35, this will cause significant deterioration.

STEP 6: CORRECT ADH/OSMOLALITY

Treatment: Desmopressin Acetate (DDAVP)

  • Use DDAVP when osmolality is high>295
  • Use 0.2 mg every other night to verify tolerance and absence of side effects especially if weight gain. Initial correction of ADH can lead to edema and rapid weight gain due to fluid retention.
  • After 5 doses – check serum osmolality, ADH and electrolytes verifying normal sodium and not too low.
  • If symptoms persist, especially on “off days”, use 0.2 mg daily.
  • Check electrolytes and osmolality after 10 days.
  • Some people (especially those with POTS) may need to be on drug daily for indeterminate basis.
  • Some may need it twice daily.
  • ADH abnormalities usually normalizes over time.
  • This treatment may also correct von Willebrand syndrome and help reduce MMP9 (and C4a) levels. Von Willebrands patients need to carry DDAVP to stop nasal hemorrhage.
  • One needs to taper DDAVP when endpoint of normal ADH for a given osmolality is reached. 
  • Children need to use 1-4 sprays based on weight and age.
  • If odd symptoms occur while on treatment, stop treatment and check electrolytes and serum osmolality.
  • Taurine can cause polyuria and Lithium can cause ADH resistance.
  • Symptoms addressed include polyuria, polydipsia, orthostatic hypotension, recurrent headaches and static shocking.

STEP 7: CORRECT ELEVATED MMP-9

Treatment: Actos and/or EPA/DHA Fish oil

  • The goal of therapy is to upregulate PPAR-gamma production and reduce MMP-9 expression.
  • Lowers TNF, leptin, MMP9, PAI-1, and raises low VEGF.
  • If low leptin-less than 7 or less than 18 years, can’t use Actos.
  • If leptin less than 7, use high dose fish oil: EPA 2.4 mg, DHA 1.8 mg daily.
  • If high or normal leptin, use Actos- low carb/amylose, high protein diet.
  • Actos 45 mg once daily for 30 days.
  • If get swollen and hypoglycemic have to stop.
  • Watch kidney function and blood sugar.
  • Actos is also implicated in bladder cancer with long term use.
  • Takes longer to work but is effective.
  • Recheck labs after 30 days.
  • High MMP-9 patients may get worse when starting CSM with Herxheimer reactions.  
  • Herxheimer reaction defined as- symptoms gotten worse, new symptoms arise, reactivation of old symptoms.
  • With an increase in MMP-9 there is worsening in row E of the VCS test.
  • Trental, progesterone, curcumin, glutamine, glutathione and phosphatidyl choline have been anecdotally shown to lower MMP-9- not part of Shoemaker protocol.

Step 8: CORRECT VEGF – Correction of Hypoperfusion

  • The previous steps may have improved VEGF.
  • If not improved, exercise is added to the protocol to increase low VEGF.
  • Graded exercise below anaerobic threshold 7 days per week is recommended.
  • Patients are asked to start very slowly but may end up exercising to a maximum of 45 minutes
  • Suitable routine eventually may include 15 minutes of cardio, 15 minutes of weights, 15 minutes of abdominal exercises.
  • Corrects low VEGF.
  • Procrit and VIP can increase VO2 max.

Step 9: CORRECT ELEVATED C3a

  • Statins show reduction in T cell activation, macrophage infiltration and vascular wall infiltration.
  • Statins inhibit an enzyme HMG-COA reductase that controls the rate of cholesterol production.
  • Must be used with Coenzyme Q10 (CoQ10) – needed by mitochondria to make ATP.
  • Coenzyme Q10 levels can be measured in the serum.
  • Start Coenzyme Q10 150-300 mg for 10 days.
  • Then start statins – Zocor 80 mg day, Pravastatin, Atorvastin, Fluvastin, Rosuvastatin and Lovastatin may all be used.
  • Statins metabolized by Cytochrome P450 3A4.
  • Drugs that inhibit CYT 3A4= Sporonox, Ketoconazole, Erythromycin, Clarithromycin, HIV protease inhibitors, Nefazodone, gemfibrozil, Biaxin, Ketek and Posaconazole.  
  • No large quantities of grapefruit juice.
  • With Lovastatin, do not exceed 20 mg dose if on danazol, diltiazem or verapamil.
  • Monitor liver function, renal function and creatine.
  • May increase cognitive symptoms and raise blood sugars.

Step 10: CORRECT ELEVATED C4a

  • Reduce C4a with erythropoietin (Procrit) 8,000 units twice weekly (Mon and Thurs) for 5-8 doses with baby aspirin. 40,000 units per vial.
  • Higher doses once per week not effective due to short half-life of 1.5 days.
  • Erythropoietin causes tissue remodeling and repair.
  • Informed consent must be signed as there is a black box warning.
  • Most practitioners now use VIP instead of Procrit.  
  • Monitor CBC, iron studies, blood pressure, D-dimer.
  • Use baby aspirin when using Procrit.
  • Check levels of C4a, TGF beta-1, T reg cells and VEGF before each dose to ensure efficiency of treatment.
  • Ensure no polycythemia occurs thus increase risk for thrombus formation.
  • Keep track of symptoms to see if improvement- breathing easier, increased mental clarity.  
  • High C4a can cause decreased cognitive function due to hypoperfusion.
  • Treating C4a can improve cognitive deficits- memory, concentration, word finding, assimilation of new knowledge, confusion, disorientation.
  • Can use VIP 4 sprays a day if cannot use Procrit.
  • High C4a can cause hypoperfusion and increased brain swelling as seen on Neuroquant. Will see high lactate (>1.29) in frontal lobes and hippocampus and low glutamate/glutamine ratio (<2.19). These findings result in cognitive dysfunction and brain fog.
  • Assess cognitive function: if abnormal, do MRI spectroscopy.
  • If MRI abnormal showing low glutamate/glutamine ratio (capillary hypoperfusion) – then use Procrit. [1]
  • Recheck MRI spectroscopy after Procrit = normal G:G, normal lactate and improvement in 6 areas of cognitive functions.

[1] Shoemaker R. Biotoxin Illness Treatment Protocol pg. 10.

Step 11: REDUCE ELEVATED TGF beta -1

  • Every effort must be made to reduce this biomarker as it represents widespread tissue involvement.[1]
  • Losartan can prevent TH17 conversion of T reg cells and thus correct TGF beta-1 levels.
  • Losartan/Cozaar 12.5 mg bid, up to 25-50mg a day.
  • Child dosage is 0.6-0.7 mg/kg/day bid.  
  • VIP also lowers TGF-b1.
  • Use 4 sprays VIP a day if can’t use Cozaar due to low b.p. Patient must meet VIP criteria.  
  • If CD4+CD25++ T reg cells <4.66% and TGF beta -1 >2,380 and blood pressure normal.
  • Treat with Cozaar 25 mg daily- start with 12.5 mg.
  • Increase to 25 mg bid if necessary.
  • Monitor TGFB monthly and blood pressure daily.
  • Transfer Factor may also reduce TGF beta-1. This is not part of the Shoemaker protocol.

[1] Berndston K. pg. 14 

STEP 12: REPLACE LOW VIP

  • If patients have cleared a number of the Dr. Shoemaker biomarkers (see below) but still have signs of capillary hypoperfusion with fatigue, unusual shortness of breath with exertion and post-exertion malaise, a trial of VIP may be the most effective treatment so far in the treatment protocol.
  • Neuroquant findings will also determine suitability of use
  • Patients must be given a VIP handout before treatment.
  • VIP is dispensed in a brown bottle, must be refrigerated in upright position. It can last for 90 days if stored properly.
  • If deficient in VIP, the final step can provide significant relief.
  • Most people will have at least 75% of their symptoms relieved before starting VIP providing all the preceding steps have been done successfully.
  • All prior steps need to be fulfilled prior to use of VIP:
  • MARCoNS must be eradicated
  • VCS must be normal
  • Lipase must be normal
  • No significant exposure can be tolerated- home must have an ERMI of less or equal to 2 or Health Effects Roster Type Species Mycotoxin and Inflammagen test (HERTSMI-2) must be less than or equal to 10
  • Once decision made to use VIP the following steps need to be taken:
  • Patients must be in the office
  • Pre -VIP administration labs: VIP, MSH (this may be one of the last hormones to correct and may need VIP), TGF-beta-1, C4A, VEGF, MMP-9, CD4+/CD25++, Vit D-25-OH, estradiol, total testosterone and lipase should also be measured
  • Baseline stress echo to measure tricuspid regurgitation/ pulmonary artery systolic pressure (PASP) – verify it does not rise over 8 mm during exercise.
  • CIRS patients will often have over 8 mm Hg elevation of PASP- this can result in palpitations and dyspnea not responsive to asthma medication.[1]
  • After bloods are drawn, test spray one dose 50 mcg in one nostril.
  • Patient observed for any symptom improvement.
  • Vital signs (b. p. pulse) followed every 5 minutes for 3 separate occasions. Look for rash.
  • Watch for improvements in shortness of breath, reduced joint pain and improved cognition.
  • Post-VIP 15 minutes, redraw TF beta-1 and C4a levels. If there is a twofold increase, hidden mold may be present.
  • Patient leaves office if they tolerate the second dose.
  • Dosing thereafter is 1 spray 50 mcg 4 times per day for 30 days.
  • Redo stress echo and blood pressure after 30 days. Redo lipase, C4a,TGF beta-1, VCS.
  • Dosage can be increased to 8 sprays or reduced to less than 4 sprays per day. 
  • One needs to watch for pancreatitis and increased lipase levels. Lipase needs to be checked monthly and any signs of abdominal pain need to be noted.
  • If lipase rises, VIP needs to be stopped.
  • One must check for gallbladder issues if lipase remains elevated.
  • If TGF-beta-1 and VCS are stable, lipase is normal and symptoms are improving, VIP can continue for 30 days tapering to twice daily and then discontinued.
  • Check at 6 months when off VIP: lipase, VCS and stress echo for any changes to PASP.
  • Can use VIP for up to 4 years without adverse effects.
  • Patients with MCS and chronic fatigue syndrome may improve over time. CFS patients will have low VIP.
  • Can use Cialis 20 mg 3 times per week if VIP low and poor response to exercise.
  • VIP will increase CD4 + CD25 + FoxP3 and reduce shortness of breath and cognitive problems.
  • However, reduced joint stiffness may be seen in as little as 10 minutes as it causes immediate endorphin release.
  • Improved exercise tolerance will occur as well as overall all symptoms will improve.
  • Tight clenched hands can open and patients able to take a deeper breath on VIP.
  • Immediate pain relief is a huge relief for most patients.
  • Cognitive issues respond more slowly.

[1] Shoemaker R. Biotoxin Illness Treatment Protocol pg. 12.

Re-exposure Protocol

The phrase used by Dr Shoemaker is that patients previously exposed who are re-exposed will become “sicker-quicker” due to the immediate upregulation of immunological markers.

The following steps to be used if re-exposed:

  1. Treat with CSM or Welchol immediately. A VCS is an excellent idea to monitor biotoxin exposure. Measure key labs:  C4a, leptin, MMP-9, TGF beta-1, VEGF, von Willebrands (if bleeding).
  2. Patient to move to safe environment immediately the issue is discovered.
  3. Stay off binders and other meds if patient’s labs and VCS stable

Re-exposure Trial

If it is needed to prove that a certain building is unsafe for occupation, the following protocol can be followed: SEQUENTIAL activation of innate immune elements (SAIIE)

  • After CSM use has ended, draw the following labs: C4a, TGF beta-1, MMP9, leptin, VEGF and CD4+CD25+
  • Stop all treatment meds- CSM and Welchol.
  • Stay away from building for 3 days
  • Document symptoms having been away from the building for 3 days. Do VCS and do same labs as above.
  • Return to the suspicious building for 8 hours on no meds. Record symptoms and redo above labs
  • Return to building for a second 8 hours on the second day. Record symptoms and redraw same labs
  • Return for the 3rd day, document symptoms and obtain labs.
  • Restart medications. Record symptom scores, and VCS. Labs get scored by office.

   VIII Sequential Activation of Innate Immune Elements (SAIIE)[1]


[1] http://www.tequestafamilypractice.com/articles/CIRS_Overview.htm#SAIIE

BASELINEDAY 1DAY 2DAY 3
VCSDeceasingDecreasingDecreasing
C4aIncreasingIncreasingIncreasing
VEGFIncreasingDecreasing (2 to TGF β-1)Decreasing
LeptinStableIncreasingIncreasing
MMP9StableSpikesIncreasing
vWF Factor VIIIDecreasingIncreasingNormalizes
vWF RistocetinNormalDecreasingDecreasing/may bleed on day 3
CD4+CD25+DecreasingDecreasingDecreasing
Compare to baselineC4a, VEGFLeptin, MMP9MMP9, CD’s, VEGF, & symptoms

Scoring the SAIIE;

  • Compare the C4a on day 1 to baseline
    • Compare Leptin on day 2 to baseline
    • Compare MMP9 as average of day 2 and 3 to baseline
    • Compare VEGF to baseline; rise on day 1, fall by day 3
    • Compare symptoms day 3 to baseline.
    • Add the values

 SAIIE Scores;

  • 5 for 100%; 4 for 80%, 3 for 70%, 2 for 60%, and 1 for 50%
    • Controls mean is 6.3
    • Cases mean is 17.9
    • TGF β-1 rapidly changes
    • CD4+CD25+; it drops rapidly.

 What is SAIIE really showing?

  1. Looking at the progression of innate immune responses- extremely sensitive C4a and TGF β-1
    1. Gene activation following receptor resistance (leptin)
    2. Bottom line; this is absolute proof of causation.
    3. A/B/B’/A/B research design.
      1. A Person at baseline
      2. B Intervention fixes them
      3. B’ Stop medicine
      4. A Re-expose
      5. B Intervention fixes them again

   This is demonstrative of:

  1. Pattern recognition; antigen presentation gone awry
    1. Inflammatory responses not controlled, neuropeptides are depleted
    2. Innate immune abnormalities become chronic as a host-response syndrome

Summary

Patients who present with a CIRS diagnosis, at present, have an enormous amount of information to ingest and, on occasion, significant skepticism to overcome. Skepticism usually rises when the patient returns to the primary care provider or specialist, to discuss the diagnostic and therapeutic path that may have been outlined. There is a common saying in life, “what you are not up on, you are usually down on.” Nowhere is this more evident than in the world of medicine. It is not uncommon for medical doctors to dismiss outright any information that is not part of their consensual reality. Even if one is not trained in this area of emerging medicine, it still requires a deep commitment to study the literature, learn the diagnostic and therapeutic criteria for CIRS and apply them to complex multi-symptom, multi system patients who fit the CIRS diagnosis.

At present, the CIRS diagnosis may be dismissed, diminished, misdiagnosed or misunderstood. It may take some time before the full scope and implications of this diagnosis make its way into clinical practice and hence consensual reality. In the meantime, it is incumbent upon practitioners of the CIRS protocol to continue learning the emerging science, particularly the role of genomics in the diagnosis and treatment protocol.

Adequate standards of remediation are another problem many patients frequently encounter. Too often I have heard of patients phoning a mold specialist who does not perform an adequate attic to basement visual inspection of the house but instead does an air sample and proclaims that the home is “mold free.”

Thanks to the recent Consensus Statement on the investigation and remediation of water-damaged buildings in case of CIRS-WD, [1] specific guidelines now exist for patients, practitioners, and indoor air practitioners to follow in cases of those patients with a known CIRS diagnosis.

It will take some time before critical mass is reached and this diagnosis and treatment protocol makes its way into everyday clinical practice. Having worked with the Dr. Shoemaker protocol for over five years, it has been my experience that if a patient is correctly diagnosed and follows the protocol exactly as it has been set out, the possibilities in their returning to good, if not excellent health, are directly proportional to the effort he applies to strictly following the diagnostic and treatment criteria. It is certainly a rewarding moment to witness patient’s symptom scores fall away as he makes progress with the protocol. The protocol does not produce overnight miracles, but at each step of the way, gains are made as the patient’s lives slowly return to normal. It is a wonderful experience to be a part of this transformation.


[1] Schwartz L, Weatherman G, Schrantz M, Spates W, Charlton J, Berndtson K, Shoemaker R. Indoor Environmental Professional Panel of Surviving Mold – Consensus Statement

Mold Remediation: How to Identify and Remove Mold from Your Home

Mold Remediation

Mold exposure is an all-too-common problem that can cause serious health complications for your entire household. Unfortunately, it’s also a difficult and potentially expensive problem to solve.

Mold is composed of small spores that can grow into fuzzy patches of fungus if left unchecked in high-moisture environments. Mold thrives in warm, moist environments on organic matter like wood, paper, and even sheetrock. 

Unfortunately, some molds produce biotoxins that can seriously affect your health and that of your family. Mold illness also isn’t as recognized as it should be within the medical community. Consequently, it’s likely that mold illness affects far more people than can be accurately estimated. 

Consider if you’ve ever been exposed to mold. If not in your home, then perhaps in a school building, your car, your holiday cabin, your church, someone’s home that you visit frequently, or at your workplace. Maybe mold spores and mycotoxins still exist on the clothing or furniture that you moved to your new home from a previous residence that was infected by. As prevalent as mold growth is, especially in older or water-damaged buildings, it’s very possible that many of us have experienced sustained mold exposure at one point or another. However, not everyone is susceptible to the chronic inflammatory responses from which genetically predisposed individuals often suffer.

The symptoms of mold exposure vary widely from person to person, but may include fatigue, headaches, weakness, digestive issues, nerve and joint pain, anxiety, sleep disturbances, shortness of breath, and autoimmune problems, among others (1). Unfortunately, mold illness may often be one of the last considerations when a physician is presented with such seemingly disparate symptoms in a patient.

Of course, mold prevention is the best way to avoid mold illnesses. Mold comprises microscopic spores and as a result it can be difficult to completely remove. However, if there is mold in your home, removal is your best option unless you decide to move out.

“In order to reverse and prevent some of the deleterious effects of mold exposure, a complete mold remediation, or removal, should be performed in your home.”

In this article, you will learn what mold remediation is, what tests you need to identify mold growth in your home, how to hire a good mold inspector, and how to remove mold from your home.

What is mold remediation?

Mold remediation is the process of identifying and removing mold from your home. This process should be thorough and comprehensive.

“One of the most important steps in recovering from mold-related health issues is removing the mold so you’re no longer exposed to it.”

Mold remediation includes conducting some home testing to assess the extent of mold growth, followed by hiring a mold inspector. Mold is then removed from your home and the contents are all cleaned. 

Not only should you remove the mold, you should also seek to fix the problems that initially caused the mold growth in your home, such as excessive humidity, ventilation problems, or leaks. This process can be expensive but the only other viable alternative to mold remediation, especially if the mold is affecting you or your family’s health, is to move to a new house.

What’s the Environmental Relative Moldiness Index (ERMI) test?

This test is an easy way to measure the extent of mold growth in your home. It involves collecting carpet dust, which serves as a reservoir for mold spores, for a specified amount of time before sending it to a lab for testing. You can perform the collection yourself using an ERMI testing kit.

Within the dust sample, the ERMI test is able to detect 36 different types of mold. ERMI scores range from – 10 to +20, with 20 being the highest mold level. However, some extreme cases of mold contamination may have ERMI scores that are higher than 20 (2). A shortened form of the ERMI is called the HERTSMI-2 test, which measures only five species of what are considered the most pathogenic mold species to humans. These are Aspergillus versicolor, Aspergillus penicilloides, Chaetomium globosum, Stachybotyrs chartarum, and Wallemia sebi. A different score system is used to evaluate these five mold species but generally a score greater than 10 is considered problematic for many individuals.  

The presence of some mold in a home is to be expected, but the ERMI test helps you to determine if there are unhealthy molds present in your residence, even if they’re not visible to the naked eye.

This can offer a great starting point for you and help you to determine if you need to move on to the next step of mold remediation, which is hiring a mold inspector.

Hiring a mold inspector

A mold inspector will provide some additional insights into the causes and sources of mold growth in your home. 

A mold inspection will involve not only air quality tests, considered to be the gold standard of mold assessment but fraught with caveats, and most certainly an ERMI test if you haven’t completed one already. The process also involves a thorough inspection of the different surfaces or areas in your home where mold could be growing or where mold spores may collect.

A mold inspector will also look for signs of past and present water damage, which is a significant risk factor for mold growth. Mold requires moisture in order to propagate. Mold lives on drywall, paper, cloth, carboard, food compost, wood, and carpet. In Calgary where I live there has been massive flooding in the past, leading to many homes and offices becoming mold contaminated, in spite of remediation attempts. 

A good inspector can identify not only active mold growth, but also areas in your home that are susceptible to mold or conditions that are likely to promote mold growth. They may be able to provide recommendations regarding how to prevent further mold growth by conducting some home repairs, improving ventilation, and sealing up areas where moisture may be able to enter.

According to the Professionals Panel of Surviving Mold, inspection involves two key steps (3). An exterior inspection should be carried out from a distance and at at close range, examining the roof, gutters, seals around windows and doors, the foundation, and areas where water may be likely to pool. An interior inspection will involve the use of several specialized tools to measure moisture and humidity levels and to count the particles in the air. Close attention will be paid to walls, crawlspaces, areas around plumbing fixtures, and carpeting, looking for actual water damage and/or evidence of condensation on wooden window and door frames.

Mold does not proliferate as greatly in drier air. Within the home, it’s important to keep humidity below 50% and a dehumidifier may be needed in certain cases. Air conditioning units, heat furnaces, and air vents can house mold spores and mycotoxins. Regular maintenance, cleaning of vents, and use of HEPA filtration is crucial to maintain safe air quality. 

You should hire a trained and certified mold inspector with the experience and tools necessary to perform a comprehensive inspection of your home. A good mold inspector will take their time, inspecting everything methodically from inside the attic all the way down to the basement. Amongst other issues they will look for water staining on structural beams, the condition of fiberglass insulation, water staining around celling pot light fixtures, roof leaks, and buckled base boards. The inspector will uncover the toilet water tank looking for mold growth, examine the front-end seal on washing machines, pull out your dishwasher and washing machine looking for water leakage, and inspect your showers and bathrooms. They should come equipped with an infrared camera or a device to measure moisture ithat’s present in drywall. If someone comes to your house, looks around for a few minutes, and sets up a five-minute air sampling device, this is not the person you need! 

Removing mold from your home

The final step of mold remediation is the remediation, or removal, itself. This a multi-step process that in most cases will require hiring a professional mold remediation team. You may or may not be advised to move out of the home temporarily while the process is ongoing.

Removing mold from structures in your home

Unfortunately, according to the Professionals Panel of Surviving Mold, structures made from organic materials, including wood and drywall, will need to be completely replaced if they’re infested with mold or even if only a small amount of mold is present (3).

This can be quite costly and requires professional help, but is the only way to ensure that the remediation is complete. It’s also best to replace caulking and seals in areas that have experienced water damage to ensure that the mold is completely removed.

Water damaged carpeting should also be disposed of. In fact, carpeting in general is a poor choice for flooring because it serves as a reservoir for dust and inactive mold spores. If that carpet becomes wet then mold can rapidly grow out of control. If carpet becomes wet, it’s recommended that it’s replaced. If a home has been contaminated with mold but the carpet wasn’t wet, the carpet still has to be extensively HEPA filtered and cleaned appropriately with Benefect Decon-30 Disinfectant.

Flexible ductwork and air filters should be completely torn out and replaced too since these are difficult to clean completely. Inadequate cleaning can lead to the reintroduction of mold into the ventilation system of your home (3).

For the structures that don’t need to be replaced, Greg Weatherman, Certified Microbial Consultant (CMC), recommends the following steps regarding cleaning (4).

  • Vacuum using a high efficiency particulate air (HEPA) rated vacuum, not a ‘HEPA like’ vacuum cleaner. Regular vacuum cleaners will suck up the mold spores only to redeposit them back into the air. 
  • Vacuum the carpet in multiple directions.
  • Empty the vacuum cleaner outside. If using a bagless vacuum clear, you should be wearing a N-95 mask and clean the inside of the vacuum cleaner with Benefect or a similar compound.  
  • Wipe down vacuum cleaner with a residue-free cleaning agent using a damp cloth.
  • Clean porous materials and surfaces that have visible mold growth with a hydrogen peroxide or 5:1 water to vodka mix. Some people find Benefact, which contains botanical essential oils, mainly thyme, to be useful. Nonporous surfaces will only require additional cleaning if they are caked with residue.
  • Vacuum once more using a HEPA vacuum.

Multiple attempts at vacuuming may be necessary before the full benefit is realized.

Depending on the extent of the mold contamination, the cleaning crew may need to take additional steps.

  • Contain and seal the relevant area with plastic containment material. 
  • The HVAC system must be isolated from the rest of the building. Taping may be necessary to seal room leaks around windows or other openings. 
  • In order to allow technicians to clean equipment and change protective gear when going in and out of the work area, an anteroom should be established to serve as an entryway. 
  • The room requiring remediation needs to be at a lower pressure than the surrounding area. 
  • A negative pressure HEPA filtration extraction unit must be used. 
  • Personnel involved in the cleanup must wear personal protective equipment (PPE) up to and including respirators and protective suits (3)

After cleaning, porous surfaces such as wood should be sealed with antifungal paint.

Removing mold from your household items

Next, you’ll need to remove mold from your personal items and belongings. As a general rule of thumb in cases of mold contamination, you should throw away anything porous that you’re comfortable getting rid of.

However, there are steps you can take to clean items that you wish to keep. As with the structures in your home, the first step is to vacuum your belongings with a HEPA vacuum (4).

Inorganic, nonporous surfaces and items such as plastics and metals can be thoroughly wiped down with a residue-free cleaner. Porous materials with visible mold growth should be cleaned with a hydrogen peroxide cleaner, Benefect, or the vodka 5:1 mixture. Using a wet and then a dry cloth method is recommended. 

  • Use disposable wipes to clean the surface twice.
  • Follow up with a dry cloth to remove any moisture.
  • Throw the wipes away without cross-contaminating your clothes or other surfaces.
  • Clean the dry cloth with hot water and borax.

After cleaning, your items should be vacuumed once more with a HEPA vacuum (4).

Items generally considered safe to keep and clean include:

  • Jewelry
  • Cutlery
  • Dishware
  • Pottery
  • Statues
  • Hi-Fi equipment and electronics
  • Artwork, although this still needs to be wiped down and cleaned 

According to Larry Schwartz, council-certified Indoor Environmental Consultant (CIEC), certain household items may require special attention or consideration. Here’s some additional guidance for household items that you may not feel comfortable disposing of (5).

  • Papers and documents: Scan them electronically and place them in long-term storage.
  • Books: Wipe down the cover with mild borax soap and water. HEPA vacuum the outside and edges of the book.
  • Upholstered furniture: Vacuum with a HEPA vacuum and wipe down with borax, vodka mixture, or Benefact.
  • Mattresses: Vacuum with a HEPA vacuum although you should strongly consider replacing your mattress as it can collect moisture, dust particles, and mold spores.
  • Bedding: Wash in laundry borax and detergent or have bedding professionally cleaned. 
  • Electronics: Disconnect the wiring and clean the cables and the exterior of the electronics or have them professionally cleaned. Computers may blow mold spores around when the fan starts up when turned on.
  • Clothing: Wash in laundry borax (sodium borax) and detergent. Borax is a natural anti-mold and antibacterial solution. One recipe is to soak your clothing for half an hour in one cup of borax to one gallon (approximately four litres) of water before washing. Be sure to wash your hands thoroughly after handling borax. 
  • Shoes: Depending on their material, they can be wiped down with borax soap and water. You may also HEPA vacuum them.
  • Indoor plants: These should be disposed of since they retain mildew and mold spores.
  • Antique rugs: Rugs are a frequent source of mold spores and are difficult to clean.
  • Toys: Stuffed childen’s toys and animal toys should be disposed of. Plastic toys can be cleaned with the recommended solutions. 
  • Washers and dryers: If you have a front-end loader washing machine, check the inner seal for mold contamination and wipe down with borax.
  • Portable air conditioners or purifiers: New filters must be used when transporting these items from a moldy environment to another area. 
  • Food: Be sure to get rid of open food packets, jars of rice, and other grains, flours, or spices.
  • Animals: Pets may need to be boarded elsewhere while your home is undergoing remediation and then thoroughly washed before being reintroduced back into the home.

If you are unsure regarding what to do, place your questionable items in a sealed container and remove this from the area you’re attempting to remediate. Be sure to use an N-95 mask and even consider purchasing a hazmat suit when working with contaminated materials.  

Although a professional remediator will need to handle the structures in your home, you can clean most of your household items yourself. This will save you some money by decreasing the workload of the remediation team (5).

Fogging for mold

The final step in remediation is fogging.

“HEPA vacuums are powerful, but they are unable to filter certain particles that are too small or light.“

This can include mold spores (3). However, fogging or misting the home with an air purifying solution, once all other remediation steps are complete, can help ensure that even these smaller particles are disposed of.

There is a certain protocol that should be followed to ensure that fogging is as effective as possible, so it should be handled by a remediation professional.

Prevention and maintenance

After remediation, you should take steps to prevent further mold contamination by performing routine maintenance on your home and taking action to fix water leaks, ventilation problems, or changes in humidity.

Mold is a very common contaminant of water-damaged or damp buildings but it has been estimated that there are over thirty other contaminants that can be found alongside mold. These include, but are not limited to, volatile organic compounds (VOC’s), gram negative and positive bacteria cell wall components, glucans, mannans, hyphal fragments, inorganic xenobiotics, antinomycetes, mycoplasma, and chlamydia fragments. 

You may want to invest in HEPA filters for your home, which can help cut down on dust and mold spores settling on surfaces such as carpets and upholstery. It’s important to use HEPA filters that filter down to 0.1 microns. Most commercial HEPA filters only filter to 0.3 microns and will not be adequate for removing mold spores or mycotoxins. The Blueair Sense HEPA filter, the IQ Air purifier, and the Austin Air purifier are three recommended brands.  

If your home is humid, you should also use dehumidifiers to remove some of the moisture from the air, which will discourage mold growth.

Post-remediation, you may also choose to do follow-up EMRI testing or have a follow-up mold inspection to ensure that the remediation was successful.

Mold illness can be daunting, especially since treatment requires not only medical care but also a potential remediation of your home. As a Shoemaker protocol certified physician, I’m uniquely positioned to help you manage and treat your mold illness. My team can also help point you in the right direction to start the mold remediation process. Contact us today.

[embed_popupally_pro popup_id=”4″]

References

  1. Hope, J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. The Scientific World Journal. 2013; 2013:767482. Published April 18, 2013. doi:10.1155/2013/767482
  2. Kamal, A, Burke, J, Vesper, S, et al. Applicability of the environmental relative moldiness index for quantification of residential mold contamination in an air pollution health effects study. J Environ Public Health. 2014; 2014:261357. doi:10.1155/2014/261357
  3. Schwartz, L, Weatherman, G, Schrantz, M, et al. Indoor Environmental Professionals Panel of Surviving Mold Consensus Statement: Medically sound investigation and remediation of water-damaged buildings in cases of CIRS-WDB. SurvivingMold.com
  4. Weatherman G. A condensed remediation plan for small microbial particles. AerobioLogical Solutions Inc. Published January 2013.
  5. Schwartz, L. Suggested protocol for preparation of home prior to fogging or ventilation treatments of the air. SafeStart Environmental.

Household Toxins: What They Are and How to Fight Back

Household Toxins: What They Are and How to Fight Back

One of the most challenging issues facing practitioners who treat patients with chronic multisymptom illnesses is identifying the exact triggers. These triggers could include food, infections, pathologies, genetics, nutrition, hormonal deficiencies, chemicals, heavy metals, stress, head injuries, and many other unknowns. When segments of these triggers are focused on and related to their environmental causes, the literature can get very specific; however, in real-life situations, it is often very difficult to clinically separate one factor from another. The question then remains: how can we best identify and isolate the core issues without breaking the bank in test costs?

The reality is that for far too long we’ve ignored the impact of environmental toxins on our health. This is because conventional medicine has largely viewed the body as separate from the world around us, and this is working to our detriment. Our modern world today is oversaturated with environmental toxins which are infiltrating our bodies at unprecedented rates. These at-home and/or occupational exposures may sometimes be acute (high levels of toxicity) or chronic (low-level and continuous). The number of toxins we are exposed to on a daily basis is in the tens of thousands. Simply put, we cannot deny their effects on our health any longer.

The Sources of Toxins

If this is the first time you’re hearing about the scope of environmental toxins present in our everyday lives and their impact on our health, the sheer number of them may surprise you.

These include, but are not limited to:

  • Pesticides present in our food
  • Off-gas chemicals from new furniture or mattresses
  • Chemicals currently permitted in cosmetics and personal care products
  • Air contaminants
  • Hormones, chemicals, and pharmaceuticals present in our public water supply
  • Hidden mold growths which release mycotoxins
  • Aluminum and nonstick cookware which release heavy metals into your food
  • Chemicals from printers and electronics
  • Gas and supplementary toxins from stoves and heaters
  • Toxic household cleaning products
  • Dust mites
  • Airborne viruses and bacteria
  • Pet dander
  • Cigarette smoke

Each item on this list has startling facts to back them. To name one particularly shocking one, an Environmental Watch Group (EWG) report co-sponsored by the U.S. Department of Agriculture found 20 different pesticides on a single batch of strawberries. In another environmental working group study, 200 common everyday chemicals out of 287 examined were found in the umbilical cord blood of newborns. These everyday toxins included pesticides, consumer product ingredients, and wastes from burning coal, gasoline, and garbage with 180 of these chemicals being known carcinogens.

The bottom line is that the sheer number of highly-toxic chemicals and biotoxins present in every aspect of life is a cause of serious concern. Yet, with there being so many different types of toxins and routes of exposure, this fact can be overwhelming. I can assure you, however, that by taking the time to learn more and make the appropriate lifestyle changes, you can significantly reduce the effects of environmental toxins in your life over time. The first step, however, is understanding this toxic burden as a cumulative effect with compounding consequences.

Which Toxins Make Us Sick?

Sadly, the toxins and chemicals that are released as part of our manufactured goods have practically no oversight. Sometimes it takes medical researchers years and even decades to fully realize the impact. These are most present today in personal care products, flame retardants on sofas, mattresses and carpets, and also pesticides in our foods (which are found in rates as high as 70% in conventionally grown food).

The net sum of toxins in our everyday environment, still largely unknown to us, have been linked to:

  • Neurodegenerative diseases
  • Developmental defects
  • Brain disorders
  • Obesity
  • Endocrine related disorders
  • Fertility issues
  • Fibroid tumors
  • Endometriosis
  • Cancer
  • Hypothyroidism
  • Autoimmune disease

Since we can’t count on the government to keep us safe from these toxins, it’s up to us to learn take the necessary precautions to protect ourselves.

So, what are the most damaging chemicals and toxins that persist in our day-to-day lives? Here are the most commons ones I have encountered in my long career practicing medicine.

Bisphenol A (BPA)  

BPA is an endocrine disruptor which mimics estrogen in the body. BPA is found in hardened plastic products, can linings, dental sealants and feminine care products. BPA is present in over half of all canned products, levels tested at levels high enough to cause birth defects. The highest levels were found to be present in chicken soup, ravioli and infant formulas. For those infants who are exposed, studies have found them to have weaker liver detoxification enzymes, particularly glucuronidation, leading to 11-fold more BPA’s in newborns and 5 fold more BPA’s in 3-6 month olds than adults.

BPA has also been associated with numerous health conditions including infertility in men and women, developmental disorders, increase risk of cancer, depression, aggression, diabetes, and obesity in children. There is also a tenuous link between BPA and polycystic ovary syndrome, premature delivery, asthma, and poor function of the liver, thyroid, and brain.

“Fragrances” & Phthalates

The term “fragrance” is used as a catch-all label for thousands of different kinds of chemicals, many of which are harmful to our health. Some of the worst chemicals that hide under the name fragrance are phthalates which have been associated with hormonal defects and  dysfunction. EWG found fragrance to be the hidden name for phthalates in 75% of 72 products sampled. Phthalates are thus the most common groups of toxins found in our daily lives due to their widespread use. They can be found in cosmetics, perfumes, cleaning products, plastic, baby products (even teething rings and sippy cups), printing inks, paper coatings, and more.

Perfluorooctanoic acid (PFOA)

PFOA is found in Teflon coated pans, Gore-Tex, stain resistant carpet, and furniture. The toxin builds up in the body and is responsible for altering hormonal processes causing infertility, cancer, and developmental issues.

Vinyl chloride

Found in furniture, household products, and interior car furnishings, vinyl chloride has been associated with liver damage, headaches, degenerative bone conditions, and enlargement of the spleen.

Benzene  

A byproduct of the combustion of crude oils, benzene is utilized in gasoline to prevent engine knocking and as a solvent in the rubber and surface coating industries.

Benzene and its by-products such as phenol, toluene and MTBE are common off-gases from furniture, carpets, and drapes. They have been associated with cancer, birth defects and immune abnormalities. The danger with these chemicals is that they bind to tissues and initiate an antibody immune reaction to the chemical attached to tissue protein, resulting in an autoimmune response.

When first exposed chronically to low-level industrial exposures of these toxins, subtle visual changes are often the first sign. Gas station workers, for example, have some of the highest levels for tragically obvious reasons. Eye irritation, burning of the nose and throat, headaches, skin rashes and memory defects are the earliest symptoms.

Pyrethroids

Found in bug sprays, pyrethroids have been linked to ADHD, autism, and premature death.

Xylenes

Found in pesticides, insect repellents, cleaners, and paints, xylene has been associated with severe oxidative stress, nausea, vomiting, and depression.

Styrene

Present in building materials, plastics, and food packaging, styrene has been associated with dysfunction of the central nervous system, muscle weakness, and irritation of mucous membranes.

Organophosphates

A very common toxin commonly found in insecticides and lice shampoo, organophosphates have been associated with abnormal behavior, aggression, depression, autism, developmental disorders, and shortened pregnancy.

2, 4-Dichlorophenoxyacetic (2,4-D)

GMO Foods such as soybeans and corn often include 2,4-D. 2,4-D is a known endocrine disruptor which means it impacts the hormones in your body and knocks them off balance.

Silicone

Although not ubiquitous, silicone is used in rhinoplasty procedures, calf enhancement for body builders and, of course, breast augmentation. Silicone has been associated with many autoimmune diseases like rheumatoid factor, antinuclear antibodies, and antibodies against brain tissue (specifically myelin) as well as specific symptoms involving the central and peripheral nervous systems. Immunosuppression induced from silicone may also make the patient especially vulnerable to viral and bacterial infections.  

These descriptions cover just a handful of the chemicals present in our everyday lives. Other common chemicals of concern are listed below and I encourage you to read further into each of these toxins to learn how they affect your health.

  • Industrial Solvents (defined as any liquid that can dissolve a substance)
  • Diphenyl phosphate
  • Methyl tertiary-butyl ether and Ethyl tertiary-butyl ether (MTBE and ETBE)
  • Lead
  • Methylmercury
  • Polychlorinated biphenyls (PCBs)
  • Arsenic
  • Toluene
  • Acrylamide
  • Fluoride
  • Perchlorate
  • Propylene oxide
  • 1,3 Butadiene
  • 1-Bromopropane
  • Ethylene oxide
  • Acrylonitrile

All of this is just the tip of the iceberg. The reality is that we come in contact with tens of thousands of chemicals on a daily basis.  There are three main areas where these toxins are propagated and harm us: in our air, our water, and our food. So let’s talk about those.


Toxins in Our Air

Most people don’t realize that the air in our homes is often more polluted than the air outside. This fact shocks my patients when they first hear about it, but is it really all that surprising?

Poor air quality in our homes and offices is often due to:

  • Faulty filtration systems
  • Poor air circulation
  • A lack of sunlight and fresh air
  • Toxic household cleaning products
  • Mold growth
  • Indoor appliances, such as gas stoves, that aren’t functioning properly

The effects of airborne toxins are always made exponentially worse in an environment with poor air circulation. You’re essentially trapping yourself in a cloud of your own allergens and toxins. Given that we now spend 90% of our time indoors creates the perfect storm for toxin to build up in our bodies via the air we breathe everyday.

Toxins in Our Water

It is a sad state affairs when we can no longer trust our tap water being safe, clean, and free of toxins. While the people of Flint, Michigan can definitely attest to this, as they have gone now four years without safe drinking water, there are concerns when it comes to our drinking water beyond just Flint.

Some may be shocked to find out these statistics about toxins in our water:

  • Pollution is by far one of our biggest killers worldwide. An average of 100 million people die each year due to pollution which makes it comparable to diseases like HIV and malaria.
  • 1 billion pounds of industrial chemicals are released into the ground every year.
  • 1 billion pounds of pesticides are used in Canada every year.
  • People who live in highly polluted places have a 20% higher risk of dying of cancer.
  • 40% of America’s lakes are too polluted for healthy ecosystems, fishing or swimming.
  • 1.2 trillion gallons of untreated sewage and Industrial waste are dumped into the U.S. water system every year.

This way of living is simply unsustainable, not to mention that we are effectively leaving the future generations to poisoned conditions. If water is the starting point, then our current way of life has become rotten without us even realizing it.

Toxins in Our Food

Pesticides in our food have become a problem of epidemic proportions. The EWG reported in 2017 that most foods grown non-organically contain some sort of pesticide contamination. As I mentioned earlier in this article, one batch of strawberry on average has 20 different types of pesticides on it. Conventionally-grown spinach, for example was found to have twice as many pesticides as any other food!

The EWG has put together a list called The Dirty Dozen: the 12 most contaminated foods. Those include:

  1. Strawberries
  2. Spinach
  3. Nectarines
  4. Apples
  5. Peaches
  6. Pears
  7. Cherries
  8. Grapes
  9. Celery
  10. Tomatoes
  11. Bell peppers
  12. Potatoes

Glyphosate, also known as Roundup, has been found to be a major food contaminant. It was officially pronounced a carcinogen in 2015. Yet, because it is produced by the agricultural giant Monsanto, court cases that would permit warning labels and restriction for glyphosate are continuously lost to this mammoth corporation.

Other contaminants in your food which are not pesticides include mycotoxins from mold, found in anything being stored for a long period of time. This includes foods like coffee, corn, cocoa, and peanuts. For the most part, the mycotoxins present in food do not cause most people trouble unless their detoxification systems are disrupted due to genetic abnormalities or have certain sensitivities to such toxins.


How to Take the Right Precautions for Toxins

If you’re concerned about your toxic burden, the first step you should take is be tested for common household toxins with your physician. I would recommend the Great Plains Laboratory – Toxic Non-metal Chemical Profile which looks for environmental pollutants known to contribute to chronic disease. Toxin tests can tell you a great deal about your overall exposure and how it might be affecting your health.

13 Steps to Reduce Toxins in Your Home

  1. Eat organic: Eating organic food is one of the best ways to reduce your toxin exposure. The amount of pesticides that are found on conventionally grown fruits and vegetables are staggering. Conventionally farmed meat contain hormones, antibiotics, and sometimes are even disinfected with chlorine. Eating organic is the best way to prevent these pollutants and toxins from being present in your body and doing you irreparable harm.
  2. Use clean personal care products: You’d be wrong to expect that personal care products are regulated to keep harmful chemicals out of them. Many of the harmful chemicals such as arsenic, lead, mercury, are permitted under the label “contaminant.” This also means manufacturers are not responsible for them making you sick. Avoid them at all costs.
  3. Use natural laundry detergent: Laundry detergent is packed with loads of unnecessary toxic chemicals. It’s truly perplexing why so many chemicals are used in laundry detergent when all that’s needed is a little baking soda and borax (sodium borate). The solution is to find alternatives to PERC drycleaners. Instead, utilize a dry cleaner using CO2 based techniques instead of PERC or silicon-based dry cleaners.
  4. Get rid of all plastics, especially BPA-containing plastics: this can be done be doing a few simple steps. Firstly, use glass water bottles whenever you can and always opt for glass when possible. Secondly, buy meats in wax paper or freezer wraps. Thirdly, store food in glass or pyrex. Fourth, when purchasing coffee bring your own mug. Fifth, do not accept ATM receipts. And lastly, and most importantly, rid yourself of all BPA-containing plastics which can easily be researched online. As a suggestion for newborns, born-free baby bottles are free of BPA. As an added suggestion, switching from packaged foods to fresh unpackaged foods lead to a reduction in urine concentration of 66% for BPA. If possible, trying to avoid plastics whenever possible is the best preventive measure.
  5. Purchase products with the MADE SAFE certification: MADE SAFE is a certification dedicated to finding products that are free of all toxins. Using MADE SAFE products will give you a better peace of mind when it comes to purchasing personal care products, household cleaning products, and more.
  6. Get rid of toxic cleaning products: This includes harsh cleaning chemicals, pesticide sprays, foggers, and any aerosol cans. If you aren’t going to get rid of any of these, at least remove them from within the house.
  7. Carefully select non-toxic furniture and mattresses: Furniture and mattresses are a major source of toxins. Fortunately, many companies are now going through certain procedures to earn non-toxic certifications. It is definitely worth it to invest a little more into where you sleep and spend many hours each night to ensure it is free of toxins and safe for yourself and your family.
  8. Avoid stain resistant materials: Stain resistant materials contain toxic chemical coatings and are found on furniture, clothing, and carpet.
  9. Only use organic landscaping practices: Every time a pet goes out into your front lawn or children plays in the grass, they come in contact with whatever chemicals are being used to care for your lawn. Use organic landscaping practices whenever possible to reduce the number of pesticides being tracked into your house.
  10. Look for non-toxic pest control solutions: Pest control products, like ant killer and insect foggers, are some of the most toxic household products we come in contact with. Avoid relying on these whenever possible and I encourage you to find non-toxic solutions.
  11. Don’t take unnecessary medications: This includes purchasing over the counter medications in large quantities. Studies have shown that we dump expired medications at unprecedented rates which end up in our groundwater and drinking water. Additionally, unnecessary medications also add to your overall toxic burden and should be avoided.
  12. Avoid conventional women’s care products: Dioxins and furans are used in the chemical bleaching processes in most female care products like pads and tampons. The vaginal wall is highly absorbent and should not come in contact with such chemicals.
  13. Don’t use aluminum or nonstick cookware: The safest cookware you can use are high-quality ceramic and medical grade stainless steel pots and pans. These high-end pieces might be a little more expensive, but they usually last a lifetime. Cast iron pots are okay if you do not have high levels of iron or ferritin on your blood work.

The Four Best Ways to Detox

It’s not enough to simply avoid toxins. You also must also take the necessary measures to promote detoxification throughout the body. The detox process should generally focus on your liver, kidneys, gastrointestinal system, lymphatic system, skin, and lungs. The best way you can help your body detox is to make sure these six organs are functioning well.

Here are my recommendations for four detoxification techniques you can practice to clean yourself of the damage that’s already been done:

  1. Exercise: This one should go without saying, but it must be mentioned. When it comes to detoxification through the pathways of your body, you need to get moving. Yes, this means exercising. Exercise supports better digestion, sweating, heavy breathing, and promotes blood flow and lymphatic flow – all factors that help remove toxins from the body.
  2. Saunas: Saunas, especially infrared saunas, are excellent for detoxification. Saunas promote intensive sweating and increased blood circulation, which reduces inflammation and enhances detoxification. Saunas have also been shown to promote detoxification of heavy metals through the skin.
  3. Detox Supplements: There are a number of supplements you can take to support the major detoxification pathways in your body. These include: Glycine, resveratrol, astaxanthin, quercetin, vitamin B, vitamin C, magnesium, zinc, milk thistle, and chlorella.
  4. Intake Glutathione: Glutathione is your master antioxidant and deserves its own place on this list. When you don’t have enough glutathione, your body is weaker in fighting inflammation caused by oxidative stress and cannot ensure proper detoxification. You can be sure you’re getting enough glutathione by taking it in supplement form.

By both reducing the number of toxins your body is exposed to on a daily basis and undergoing detoxification, you will begin to feel healthier and rejuvenated. Your perspective on life will also forever be changed.

Sadly, given current trends, the number of toxins we come across on a daily basis will only continue to grow. This means that it is up to you and the public at large to stay well-informed on which toxins threaten your health and work to reduce its impact – Your health depends on it.


How can we help?

Environmental toxins can be difficult to deal with. Dr. Hoffman and our clinic team are here to help and support you.

Your next step is to contact us, talk with our staff about your options and booking an appointment with Dr. Hoffman.

Contact The Hoffman Centre Today


Predicting plasma concentrations of BPA in Young Children. Environmental Health Perspectives. 2009

2 Food Packaging and Bisphenol A and Bis(2-Ethylhexyl) Phthalate Exposure. Rudel R et.al. Silent Spring Institute

Resources

https://www.ewg.org/foodnews/summary.php#.WslCM9PwZE9

https://www.ncbi.nlm.nih.gov/pubmed/24556010

https://www.healthline.com/nutrition/what-is-bpa#section7

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664337/

https://www.ncbi.nlm.nih.gov/pubmed/9577937

https://www.ewg.org/research/teen-girls-body-burden-hormone-altering-cosmetics-chemicals/cosmetics-chemicals-concern#.WslUo9PwZE8

https://pubchem.ncbi.nlm.nih.gov/compound/Pentadecafluorooctanoic_acid#section=GHS-Classification

http://www.ccohs.ca/oshanswers/chemicals/iaq_intro.html

https://cfpub.epa.gov/roe/chapter/air/indoorair.cfm

https://www.cnn.com/2018/04/07/us/flint-michigan-water-bottle-program-ends/index.html

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1497491/

https://www.ewg.org/foodnews/dirty_dozen_list.php#.Wslmu9PwZE9

https://www.reuters.com/article/us-usa-pesticides-monsanto/u-s-judge-halts-california-plan-to-require-glyphosate-warnings-idUSKCN1GB2H0

https://www.independent.co.uk/life-style/health-and-families/chlorine-washed-chicken-qa-food-safety-expert-explains-why-us-poultry-is-banned-in-the-eu-a7875131.html

https://www.fda.gov/Cosmetics/ProductsIngredients/PotentialContaminants/ucm452836.htm#limits

https://madesafe.org/

Website. (n.d.). Retrieved June 21, 2018, from www.ewg.org.

Toxic Mold Illness: Is Your Home Causing Your Mysterious Symptoms?

If you are suffering from chronic symptoms such as asthma, fatigue, or brain fog, and you’ve struggled to find a proper diagnosis or relief, it might be time to examine your environment more closely.

Toxic mold illness and its effect on the immune system, called chronic inflammatory response syndrome (CIRS) is a perfect example of the power of our environment to impact our health in a dramatic fashion.

Many toxic molds are formed in buildings that have suffered water damage through flooding, condensation or high humidity. It is estimated that as many as 50 percent of homes have poor indoor air quality with water damage and the resultant mold biotoxins and associated inflammatory particles being one of the major contributors. With indoor air pollution accounting for up to 50 percent of all illnesses in the United States, this is a very serious contributor to patients’ suffering, and deserves to be raised as a major factor when enquiring into patients’ health history and timeline of symptom presentation.

Globally, air pollution is an epidemic, killing an estimated seven million people and is responsible for one in eight global deaths each year. This is a staggering number, and the fact that mold illness is one of the contributors to this epidemic, is still relatively undiscussed and unknown in traditional medical clinics, needs to change. Let’s shed some light on this invisible illness.

The Invisible Illness – Mold Toxicity

Mold is quite literally an invisible killer because often you cannot see it. Caused by multiple different types of fungi, mold reproduces by forming tiny spores, which float away and are unseen by the naked eye.

Not only are mold spores invisible, but they produce even smaller secondary mycotoxins which are able to sneak through the body while wreaking havoc and remaining undetected by the immune system. These mycotoxins are extremely small, fat soluble molecules.

These molecules are particularly dangerous because they are capable of passing through your cell membranes without being carried through the bloodstream – making them extremely difficult for your immune system to identify.

Without identifying and helping your immune system recover from a buildup of toxin exposure, you could unnecessarily suffer from long term negative health consequences. Helping the public understand and become aware of CIRS is one of the best ways we can rectify unnecessary suffering.

Let’s examine the 13 symptoms of mold illness or CIRS, 4 common misconceptions, and 11 steps you can take towards effective treatment.

13 Toxic Mold Illness Symptoms

The problem with toxic mold illness is it can feel like a phantom illness. Mold toxicity symptoms seem unrelated and can cause doctors to look in all the wrong places for a diagnosis.

Many sufferers of mold illness or CIRS first endure years of misdiagnosis or are even dismissed as having an illness that’s psychosomatic (in the mind). If you are suffering from a myriad of seemingly unrelated symptoms, it’s time to consider your home and work environments.

Here are the 13 most common mold symptoms (Dr. Shoemaker has identified 37 symptoms in total). It’s time to see your doctor if you suffer from any of the following symptoms of mold sickness:

  1. Cognitive issues such as headaches, brain fog, memory problems, difficulty concentrating, and mood swings
  2. General fatigue and weakness
  3. Muscle aches, joint pain, and morning stiffness
  4. Numbness and tingling of the skin
  5. Light sensitivity, blurred vision or red eyes
  6. Asthma, persistent coughing, sinus issues or shortness of breath
  7. Skin tingling or numbness
  8. Vertigo and tremors
  9. Metallic taste
  10. Temperature fluctuations or night sweats
  11. Increased urination and excessive thirst
  12. Changes in appetite
  13. Abdominal pain, nausea, diarrhea, and bloating

As you can see, the symptoms of mold illness are varied and may even appear unrelated. It’s the nature of these broad reaching symptoms that keeps the cloud of mystery over CIRS.

Only through drawing more public attention and dispelling common myths around CIRS can we get closer to achieving better diagnoses and treatments. Let’s start that process by taking a closer look at the four common misconceptions surrounding mold illness.

4 Common Misconceptions of Mold Illness

Toxic mold illness is gaining traction in the media but with that come some misconceptions. Let’s clear up some of these fallacies regarding mold illness right now.

1.  Mold Illness Isn’t That Common

Even though mold illness isn’t widely discussed, it is very prevalent and the public needs more information on CIRS. Approximately one in four have the potential for developing CIRS if they are exposed to sufficient biotoxins and inflammagens (other toxic compounds released by water-damaged buildings).

And unfortunately, these biotoxins are estimated to impact as many as half the homes in the United States, making CIRS an illness of major concern. It’s important to spread awareness of mold toxicity and prevalence so that people can take the right steps to keep their family safe in their homes and places of work.

2.  Mold Illness is Caused by Mold

Even though “mold” is in the description, mold illness is actually a complex health condition that fits more appropriately under the title of chronic inflammatory response syndrome or CIRS.

Originally described by Dr. Ritchie Shoemaker in the late 90s, there are now over 1700 scientific articles on CIRS to date.

The causes of CIRS are collectively known as biotoxins and are frequently associated with water-damaged buildings, though they can occur without water damage.

These biotoxins include:

  • Fungi with mycotoxins
  • Bacteria with secondary endotoxins (including Borrelia and Babesia – organisms associated with tick-borne illness)
  • Actinomycetes
  • Mycobacteria
  • Beta Glucans
  • Hemolysins (toxins produced by bacteria, often residing in deep nasal passages).
  • Microbial Volatile Organic Compounds (VOCs)
  • Cell wall fragments
  • Protozoa
  • Building material VOCs

Not everyone will become sick if they are exposed to sufficient levels of any of these toxins. They are fortunate to be part of the 75 percent of the population whose immune system recognizes these toxins and is able to neutralize them.

However, those with specific human leukocyte antigen (HLA) genes have an immune system that isn’t able to identify these toxins. If your body can’t identify these biotoxins, then it is unable to eliminate them from the body. These biotoxins initiate a significant inflammatory response called CIRS.

3. CIRS Looks the Same for Everyone

Actually, it appears that everyone has differing levels of mold sensitivity. Genetic predisposition seems to play a role in how likely you are to develop CIRS.

About 25 percent of the population is genetically susceptible to developing CIRS, while two percent are highly sensitive and more likely to experience disabling symptoms when exposed to biotoxins.

The varying levels of sensitivity to biotoxins makes CIRS a difficult illness to diagnose. Furthermore, those suffering from mold illness are often misdiagnosed or their condition is overlooked altogether.

Only through additional studies, examination, and public awareness can we begin to improve diagnosis rates for CIRS.

4.  Removing Environmental Exposure Cures the Symptoms

It seems obvious that the first step of tackling your CIRS would be removing exposure to biotoxins. But that isn’t always enough.

Sure, removing the source of toxins is great in theory, but even professionals have a hard time fully eliminating all the mold and spores. If it’s at all possible, a complete move from the contaminated area is best. Unfortunately, many cannot afford to completely remove themselves from the toxic environment.

Luckily, there are other steps you can take to help your body repair some of the damage caused by harmful biotoxins or improve your health if you are not able to completely remove yourself from the environment.

Take Action – 10 Treatments of Toxic Mold Illness

If you’ve been diagnosed with CIRS there are steps you can take to help alleviate your symptoms.

The steps of the Shoemaker Protocol outlines a detailed treatment plan on the impacts of toxic mold. 10 treatments I recommend include:

  1. First and foremost, remove yourself from the environment to the best of your ability. Begin the process of remediation of your water-damaged environment. It is best to consult an expert in the field who has been trained in the Shoemaker method of mold remediation.
  2. Invest in a high-quality indoor HEPA air filter capable of removing particles less than 0.1 microns. Most commonly purchased HEPA filters only filter particles to 0.3 microns and above.
  3. Test for and treat any nasal bacterial growth, such as MARCONS .
  4. Use cholestyramine, Welchol (known as Lodalis in Canada) to aid your body in removing the toxins by binding to them. Be sure to avoid constipation while using binders. Add magnesium oxide or citrate powders to prevent constipation during your detoxification process.
  5. Eliminate gluten and remove mycotoxin-rich foods, including wheat, barley, rice, oats, rye, peanuts, and brazil nuts.
  6. Eliminate amylose rich food, sugar and alcohol.
  7. Correct androgens such as DHEA and testosterone.
  8. Correct your cortisol and ACTH levels.
  9. There are several other biomarkers that can be examined and corrected with the guidance of your doctor such as ADH/osmolality, MMP9, VEGF, C3a, C4a, TGF beta-1, and VIP. Be sure to discuss these factors with your doctor.

It’s really a wonderful thing to finally see a comprehensive look at human health begin to hit the mainstream. And while it’s an approach you’ve been following for some time now, it’s important that it continues to spread far and wide.

Through the 7 Stages of Health and Transformation we can examine health impacts such as toxic burden through a lens that’s more complete and acknowledges the complexity of human health.

Mold illness is a perfect example of how toxins found in the 1st stage – the Extended Body – can lead to an array of seemingly confusing symptoms. If you are suffering from chronic illness – especially any of the symptoms listed above – be sure to consider mold and its resultant toxic effects, as a possible contributor.

Do your symptoms improve when you’ve been on vacation? Have you been looking for solutions to an illness with little to no success? Mold toxicity is not usually a factor many practitioners look at first. Mold illness is quite literally “out of sight, out of mind” but it could be the solution to your mysterious health woes.

As we mentioned earlier, CIRS is still a relatively unknown illness and spreading the word is vital to helping those that suffer. Share this article to help spread awareness and aid in calling attention to a debilitating and misunderstood illness.

[embed_popupally_pro popup_id=”4″]

Resources:

https://www.survivingmold.com/docs/HOFFMANESSAY1.PDF
https://www.survivingmold.com/docs/CONSENSUS_FINAL_IEP_SM_07_13_16.pdf
https://www.survivingmold.com/docs/MEDICAL_CONSENSUS_1_19_2016_INDOOR_AIR_KB_FINAL.pdf
https://www.truthaboutmold.info/statisticshttp://www.survivingmold.com/mold-symptoms/molds-mycotoxins-more
http://www.survivingmold.com/docs/Berndtson_essay_2_CIRS.pdf
https://hoffmancentre.com/wp-content/uploads/2016/12/Steps-of-the-Shoemaker-Protocol. pdf

Evidence-Based Medicine in the World of Mold Illness

The practice of evidence-based medicine (EBM) is held out as the gold standard of practice when it comes to evaluating how best to treat certain conditions. As this article will outline, nowhere is this standard in more disrepute than in the evidence-based practices currently in use on how best to treat mold related illness.

What is Evidence-Based Medicine? The term "evidence-based medicine" (EBM) was first used in 1990 by G.H. Gyatt, a professor from McMaster University Canada, but a broader description of EBM appeared in 1992 when the Evidence-Based Working Group published a new approach to teaching the practice of medicine in JAMA. (1) The article stressed that “evidence-based medicine de-emphasizes intuition, unsystematic clinical experience, and pathophysiological rationale as sufficient grounds for clinical decision making and stresses the examination of evidence from clinical research.(2)” The article emphasized that this would require “new skills of the physician, including efficient literature searching and application of formal rules of evidence evaluating the clinical literature.(3)” Tradition, anecdote and theoretical reasoning based on the basic sciences would be replaced by evidence from high-quality, randomised, controlled trials and observational studies, in combination with clinical expertise and the needs and wishes of patients.(4)

On the Internet, numerous articles discuss other potential definitions of the term "evidence-based medicine"(5). Sackett et al. define EBM as “the integration of best research evidence with clinical expertise and patient values”(6). Another definition states that “EBM is nothing more than a process of life-long, self-directed learning in which caring for patients creates the need for clinically important information about diagnosis, prognosis, therapy, and other clinical and health care issues.” A further definition suggests that EBM is “an evolutionary progression of knowledge based on the basic and clinical sciences and facilitated by the age of information technology.(7)”

Many of the above definitions arose from a BMJ article published in 1996, which stated that EBM is the conscientious, explicit and judicious use of the best current evidence in making decisions about the care of individual patients. The practice of evidence-based medicine involves integrating individual clinical expertise with the best available external clinical evidence from systematic research.(8)

Evidence-based medicine requires asking relevant clinical questions concerning the patient’s issues, performing a literature search for relevant research data to support or refute diagnostic and/or treatment approaches, critically appraising the literature regarding its validity and applications, and then implementing one’s findings and insights in a clinical setting.

Twenty-five years ago, evidence-based medicine, which involves utilizing the medical literature to effectively guide medical practice, was considered profound enough to be described by the initial authors as a paradigm shift in the way medicine was to be practiced. The authors reported Thomas Kuhn’s description of a scientific paradigm as “[a way] of looking at the world that defines both the problems that can legitimately be addressed and the range of admissible evidence that may bear on the solution”(9). When defects in an existing paradigm accumulate to the extent that the paradigm is no longer tenable, the paradigm is challenged and replaced by a new way of looking at the world.

Some of the shift toward evidence-based medicine was initiated due to a loss of confidence in the traditional medical model and the studies that had initiated those practices. Larry Dossey M.D. commented on many of the scandals that rocked the confidence of healthcare consumers at the end of the last century(10). “The uncertainties of medicine are cause for celebration,” Dossey wrote. “Modern medicine is losing some of its invincibility. Many of the rules of good health that have guided patients and physicians for decades have taken a beating from which they may not recover. The almost blind allegiance we once had to the treatments offered has been severely undermined by these studies — some of the absolute certainties are no longer as absolutely certain.”

First, there was the Vioxx drug scandal, in which many people died from heart disease after consuming what were thought to be relatively innocuous anti-inflammatory drugs. Compounding the problem was the fact that this particular drug had been marketed as being relatively safe. Furthermore, evidence emerged that the drug companies had known for some time that the drug had an increased incidence of cardiac side effects, but they had chosen to hide these negative findings to ensure a profit.

In the Women’s Health Initiative study(11), hormone replacement therapy (HRT), specifically Premarin and Provera, once a mainstay of post-menopausal symptom management and considered to be safe, was shown to actually increase women’s risk of heart disease, stroke, thrombosis and breast cancer. The risks of increased cardiovascular disease (CVD) and breast cancer were concluded to far outweigh the benefits of osteoporosis protection and colon cancer reduction. Millions of women, to the fanfare of massive nation-wide news coverage, were immediately withdrawn from hormone replacement therapy as a result of these findings. The sales of these two drugs dropped 50% in one month. The American Association of Clinical Endocrinologists, (AACE), the American Congress of Obstetricians and Gynecologists (ACOG) and the North American Menopause Society (NAMS) recommended HRT use only for short-term symptom control.

Later critiques of the study pointed out some bias and manipulation of data, including but not limited to the following:

  1. Many women chosen for the study were not in the typical age range for HRT – they were, on average, 12-15 years past the age of menopause and had significant baseline cardiovascular and coronary artery disease (CAD) at the initiation of the study.
  2. Approximately 74 percent of the women included in the study had never used HRT before and were outside the 3-4 year post-menopausal window of opportunity for HRT, in which cognitive and cardioprotection from HRT was maximal.
  3. Premarin was the estrogen used in the study. Premarin is a conjugated equine estrogen drug with 50 percent estrone (known to increase breast cancer risk prior to the WHI study), equilin and equilenin, both of which have unknown activity on human estrogen receptors. The WHI study was not undertaken with human estrogens (E1=estrone, E2=estradiol and E3=estrone). Premarin is an oral equine-derived preparation and is known to increase liver coagulation proteins, thus increasing the risk of stroke and cardiac events. Transdermal estrogen was not used, which has shown no association with the increased activation of liver clotting proteins. NAMS preaches that there are no randomized, placebo-controlled trials to support the claims of increased efficacy or safety of compounded, bioidentical hormones; however, there is a plethora of studies demonstrating the superior efficacy and safety of pharmaceutical bioidentical hormones over non-bioidentical, synthetic hormones.
  4. Progestin was the chosen progesterone preparation. This is a medroxyprogesterone acetate preparation that had already been shown to have an unfavorable effect on lipid profiles prior to the WHI trial.

Much criticism was levelled against the WHI study when the data were placed within a clinical perspective and further studies reached different conclusions. The results of the WHI and the Heart and Estrogen/Progestin Replacement Study (HERS) trial, when reassessed, were shown to not apply to younger women, specifically those aged 50-60. In most of the subsequent studies, there were no cardiovascular deaths among 6,000 women on HRT, as compared to several deaths in the placebo group (12). There was overwhelming evidence that the anti-atherosclerotic effect of HRT depended on the time of initiation and that early initiation was protective.

With regard to knee surgery, researchers proved that performing arthroscopic surgery on an arthritic knee, once a mainstay of surgical interventions for this condition, was no more effective than administering an anesthetic, making a skin incision, and performing a sham surgery. The outcomes in terms of pain and symptoms after either of these two procedures were virtually the same. The value of mammograms has also been seriously questioned, and it is unclear as to whether or not a mammogram has any influence on the number of women dying from breast cancer each year.

These observations are supported in the literature, which shows that many medical findings and treatment suggestions previously taken as the gold standard do not stand the test of time. John Ioannidis, known as a meta-researcher who has based his career on researching the validity of medical research findings, has shown time and time again in published studies that as many as 90 percent of the published medical information that doctors rely on is flawed (13). Eighty percent of non-randomized studies (the most common type of studies) turn out to be wrong, and 25 percent of gold-standard randomized studies turn out to be wrong, as do 10 percent of platinum-standard large randomized trials. One of his papers (14) discussed his belief that researchers were frequently manipulating data analyses, choosing career-advancing findings rather than good science and using the peer-review process to suppress opposing views (15). In perhaps one of the most ignominious examples of medical science undergoing a dramatic reversal in treatment approach, Dr. Egas Moniz received a Nobel prize in 1949 for his pioneering of the frontal lobotomy in 1936 to treat incurable mental illness (16). Times do change, and sometimes, they change radically.

A Wall Street Journal article written by Ron Winslow entitled Study Questions Evidence Behind Heart Therapies (17) discussed a study that revealed that less than 11 percent of 2,700 recommendations commonly made by cardiologists were supported by scientific evidence. Furthermore, many of the dogmatic recommendations and guidelines created by cardiologists are formed by individuals who are connected in some financial way with the pharmaceutical companies (18). Another study showed that 85 percent of individuals who had stents or angioplasties to treat their blocked coronary arteries did not need them. Furthermore, the group that did have the surgical procedures ended up much sicker than the individuals who treated their condition with drugs alone (19). Thus, more critical evaluation of standards of practice was needed.

The original 1992 Evidence-Based Medicine Working Group set out specific criteria for assessing the strength of evidence that supports clinical decisions (20). Has the diagnostic test been evaluated in a patient sample that included an appropriate spectrum of mild and severe disease, treated and untreated disease and individuals with different but commonly confused disorders (21)? Was there an independent, blind comparison with a gold standard of diagnosis (22)? Was the assignment of patients to treatments randomized (23)? Were all patients who entered the study accounted for at its conclusion (24)? Lastly, were explicit methods used to determine which articles to include at its conclusion (25)?

Evidence-based medicine utilizes specific steps to arrive at conclusions:

  • Ask the right question using an acronym PICO (26). P=Patient or problem, I=Intervention, C=Comparison intervention, O=Outcome.
  • Acquire the best evidence by searching various databases, including but not limited to PubMed, Embase and Cochrane Library. Evidence-based medicine has various levels or grades for use in assessing the strength of studies.
  • Appraising the evidence: Is the study valid and relevant? What were the results of the study? Will the results help in treating the patient?
  • Apply the evidence. Once the evidence is obtained, it must be filtered through the patient’s value systems and the level of the practitioner’s core competencies. Shared decision making is essential once the risks and benefits have been explained.
  • Performance assessment. Whether this approach is helping and assisting the patient to achieve his or her anticipated and expected health goals must be determined. This is done by assessing the four steps listed above.

There are four levels of evidence that are used when assessing the strength of studies via an EBM approach.

  1. Level I – This is considered the top level of evidence, and it is derived from randomized, double-blind, placebo-controlled trials and/or meta-analyses that combine the evidence from these trials. Meta-analyses are considered to be the most eligible for Level I status, but they too have come under some criticism as a means of evaluating critical evidence. Many studies that are combined in a meta-analysis are homogenous and lack sufficient outlying evidence.
  2. Level II – This evidence is not considered quite as reliable as that from Level I. This evidence comes from controlled trials without randomization, cohort or case-control analytic studies and multiple-series studies.
  3. Level III – This evidence is based on expert opinion from those specialized in one particular area under investigation. Most often, there are no control groups, and sample sizes are small. This approach can often lead to a large margin of error unless statisticians compile the evidence from all expert opinions.
  4. Level IV – This evidence is based on personal experience and is the least desirable source of evidence because it lacks statistical validity.
    The original working group emphasised that it would require a specific teaching course and orientation, as taught at the McMaster University Medicine Residency Program, Department of Medicine, in order to critical appraise journal articles and arrive at the bottom line regarding the strength of evidence and how it may bear on the clinical problems in question.

According to the original JAMA article, the residents “learn to present the methods and results in a succinct fashion, emphasizing only the key points. A wide-ranging discussion, including issues of underlying pathophysiology and related questions of diagnosis and management, follow the presentation of articles. They always substantiate decisions or acknowledge the limitations of the evidence and discuss the literature retrieval, the methodology of papers and the application to the individual patient. (27)” This article emphasised that this “new paradigm will remain an academic mirage with little relation to the world of day-to-day clinical practice unless physicians-in-training are exposed to role models who practice evidence-based medicine”. McMaster University recruited internists with training in clinical epidemiology and the “skills and commitment [needed] to practice evidence-based medicine. (28)” This is a tall order for a busy clinically orientated profession, and even this article agrees that practicing in this way is fraught with complexity and difficulty. Furthermore, when first published, the authors asked whether advocating evidence-based medicine in the absence of definitive evidence of its superiority in terms of improving patient outcomes is an internal contradiction (29).

One of the challenges facing a clinically trained and clinically based practitioner who does no in-house research and whose practice is full of competing demands is how to best evaluate the available evidence and make the best treatment decisions for patients who present every day with complex problems. The average physician spends far beyond 40 hours per week in the office, seeing patients, managing staffing issues and dealing with paperwork.

The available paths to researching evidence-based literature and applying that information to complex patients with a multitude of issues are as follows:

  1. Read journal article summaries at night with a critical eye on the quality of the research presented. Many doctors have a strictly clinical background, not a statistically oriented, research-based background, and therefore, they may lack the knowledge to interpret research articles critically.
  2. Read the opinion pieces or position papers of others who have read the original articles and commented on the quality of the research presented in association or interest group publications. Many of the position papers published by specific associations may not have the current best evidence and may not represent the best science available.
  3. Attend conferences where the presenters, one assumes, are leading the field that the conference concerns, have done the necessary research and are presenting information based on Level I and Level II evidence-based research.
  4. Listen to drug company reps who visit one’s office with the details of the research concerning their products, which is presumably biased due to vested interests whether the product in question is a supplement or a drug.
  5. Listen to patients’ summaries of their internet searches and attempt to interpret their evidence into rational decision making.
  6. Read up on what one’s colleagues are discussing and/or referencing in online discussion groups.

From these beginnings, evidence-based medicine has had some major achievements. The Cochrane Collaboration was established to collate and summarise evidence from clinical trials, methodological and publication standards for primary and secondary research were established, national and international infrastructures were built to develop and update clinical practice guidelines, resources and courses were developed to teach critical appraisal and new knowledge bases for implementation and knowledge transition were built (30).

However, since evidence-based medicine was first introduced and adopted, many cracks in the paradigm have appeared that warrant careful appraisal:

  1. The co-opting of clinical trials by invested drug manufacturing and medical device interests and the manipulation of data to suit endpoint outcomes has become more subtle and harder to detect. These companies often set the research agenda, decide what is counted as a disease (i.e., sexual arousal disorder, which is treated with sildenafil), decide which tests and treatments will be compared and choose the efficacy outcome measures (31). In addition, setting inclusion criteria to select those most likely to respond to treatment, manipulating the dosing of both intervention and control drugs and selectively publishing positive studies (while suppressing negative outcomes) in leading peer-reviewed journals, with the assumption that their trials are unbiased, creates serious legitimacy issues regarding the conclusions reached. One review of industry-sponsored trials of antidepressants showed that 37 of 38 had positive findings but only 14 of 36 trials with negative findings were published (32). Psychiatric prescription and drug trials are at the centre of many of these controversies (33). Among the RTC studies in psychiatric journals, those that reported conflicts of interest were five times more likely to report positive results. Large drug companies do not fund and are not interested in treatment interventions that do not support a pharmaceutical intervention.
    Many studies that show the long-term benefits of compounded bioidentical hormone replacement therapy interventions do not make it to mainstream medical journals for these very reasons. A very contentious JAMA-published article, a retrospective observational study, indicated the negative effects of testosterone replacement therapy on cardiovascular disease, and this article changed the way that testosterone therapy was used in male andropause, despite the fact that many prior RCT studies had shown no such impact or favourable outcomes (34).
  2. The co-opting of policy makers (politicians) by the drug industry affects the introduction of certain evidence-based policies (35).
  3. A surplus of evidence results in unmanageable clinical guidelines (36).
  4. Large trials are designed to achieve marginal gains in a saturated therapeutic field and may tend to overestimate potential benefits. After many of the large early gains in research (the use of antiretroviral drugs in HIV and the use of triple antibiotic therapy in H. Pylori), new research has had to shift its focus to marginal gains in often overpowered trials that tend to underestimate harm (adverse effects undetected) and overestimate benefits (effects that are statistically but not clinically significant (37)). GlaxoSmithKline was fined $3 billion for multiple criminal and civil offenses, such as false reporting, the unlawful promotion of medicines and failure to report safety data (38).
  5. The overemphasising of computerised decision support systems and defensive decision-making support technologies, as well as inexperience with complex presentations that do not comply with simple guidelines, may interfere with more experienced and nuanced clinical decision making on the part of an experienced practitioner who is somewhat accustomed to tolerating ambiguity and uncertainty in clinical decision making (39).
  6. Decision making may be driven by non-clinical staff who are incentivised by financial endpoints and not by the nuanced quality of care for complex individual patients. “Patients may often feel tyrannized when their clinical management is inappropriately driven by algorithmic protocols, top-down directives and population targets (40).”
  7. Simple and/or complex algorithms do not fully apply to an aging population with complex presentations and comorbid conditions. Each person is genetically and biochemically unique (as is only too well demonstrated in the CRS population), and although specific guidelines, as outlined by Dr. Shoemaker, must be followed to achieve success, there may still be many comorbid complexities that render the application of these same strict guidelines somewhat problematic, i.e., a patient with CIRS who has had a previous traumatic brain injury, complex early developmental trauma and a borderline personality disorder.

The authors of this critical 2014 BMJ paper, entitled “Evidence-based medicine: A movement in crisis?” suggest launching of a new campaign for what they termed “real evidence-based medicine”. According to them, this is how to best describe what they mean by real evidence-based medicine and the remedying solution:

What is real evidence-based medicine, and how do we achieve it? Real evidence-based medicine:

  • Makes the ethical care of the patient its top priority.
  • Demands individualised evidence in a format that clinicians and patients can understand.
  • Is characterised by expert judgment rather than mechanical rule following.
  • Shares decisions with patients through meaningful conversations.
  • Builds on a strong clinician-patient relationship and the human aspects of care.
  • Applies these principles at community level for evidence-based public health.

Actions to deliver real evidence based medicine:

  • Patients must demand better evidence that is better-presented, better-explained and applied in a more personalised way.
  • Clinical training must go beyond searching and critical appraisal to hone expert judgment and shared decision-making skills.
  • Producers of evidence summaries, clinical guidelines, and decision support tools must take account of who will use them and for what purposes and under what constraints they will be used.
  • Publishers must demand that studies meet usability standards, as well as methodological ones.
  • Policymakers must resist the instrumental generation and use of “evidence” by vested interests.
  • Independent funders must increasingly shape the production, synthesis, and dissemination of high-quality clinical and public health evidence.
  • The research agenda must become broader and more interdisciplinary, embracing the experience of illness, the psychology of evidence interpretation, the negotiation and sharing of evidence by clinicians and patients, and the prevention of harm from over-diagnosis.

I believe some of these revised criteria have been met by Dr. Shoemaker and his co-authors. Dr. Shoemaker has published critiques of what has passed for evidence-based medicine guidelines in the management of mold illness prior to his ground-breaking work. The American College of Occupational and Environmental Medicine (ACOEM) and the American Academy of Asthma, Allergy and Immunology (AAAAI) published in 2002 and 2006, respectively, guidelines reporting that mold exposure was not capable of producing human illness. Much of the ACOEM “evidence” was based on opinion papers by defense consultants in litigation regarding water-damaged buildings (Bruce Kelman and Ronald Gots) and cited no human studies as reference material (41). Dr. Shoemaker cited an article in the Wall Street Journal and an article by Craner that exposed the bias and concealed conflicts of interest of the ACOEM authors: “there is nothing evidence-based in either the ACOEM or AAAAI, as that process begins with the observation of affected patients.” Dr. Shoemaker is clearly using the criteria regarding the best way to practice evidence-based medicine in his criticism of their lack of fulfillment of these criteria in publishing these opinion papers.

I have relied almost exclusively on Dr. Shoemaker and various co-authors of certain papers to understand the complexity of this multilayered condition. Dr. Shoemaker is extremely insistent that the steps to be followed in the diagnosis and treatment of this condition must follow the guidelines set out by his own research, as well as clinical practice and treatment guidelines. It is obvious that he has followed an evidence-based approach in this undertaking. Dr. Shoemaker began his original work with CIRS when he observed that patients with a mysterious disease seemed to improve when prescribed a lipid-lowering drug, cholestyramine. Based on that original observation, he explored the biology and pathophysiology of the disease processes in patients, using the best evidence available at the time, without the influence of financial interests. As he learned, he explored further hypothesises, published numerus studies, wrote books, collaborated with other researchers and lectured on the subject. He continues to utilise the best evidence-based practices in an attempt to understand the genomics that underlie CIRS and how the use of VIP (and the rest of the CIRS protocol) influences the proteomic and Neuroquant findings of affected individuals.

The proof regarding whether an evidence-based approach is effective in managing CIRS patients is whether the patients involved in the study enjoy improved health as compared to controls. At present, there are no long-term randomized trials of the Shoemaker approach to treating CIRS. In other words, his research may not have fulfilled the Level I criteria regarding what type of research best characterises evidence-based medicine. However, his work has nonetheless systematically fulfilled most of the other criteria in that it is patient-centered and documents responses to care that are quantifiable and reproducible.

[embed_popupally_pro popup_id="4"]

 

Resources

(*1) Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 1992; 268: 2420-5.
(*2) Ibid
(*3) Ibid
(*4) Greenhalgh, T., “Evidence-based medicine: a movement in crisis?” BMJ 2014; 13 June, 348
(*5) http://researchguides.uic.edu/ebm
(*6) Sackett D.L., et al., “Evidence-Based Medicine: How to Practice and Teach EBM.” Edinburgh: Churchill Livingstone.
(*7) Doherty, Steve. “Evidence-based medicine: Arguments for and Against.” Emergency Medicine Australasia 2005; 17: 307-13.
(*8) Sackett, D.L., Rosenberg, W.M.C., Gray, J., Haynes R.B., Richardson W.S., “Evidence-based medicine: what it is and what it isn’t.” BMJ; 312:71-72.
(*9) Kuhn, T.S., The Structure of Scientific Revolutions. Chicago, Ill: University of Chicago Press; 1970
(*10) Dossey, L., Alternative Therapies Sept/Oct 2002, Vol. 8, No.5 32
(*11) Rossouw, J.E.1, Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., Kotchen, J.M., Ockene, J. Writing Group for the Women's Health Initiative. (2002). “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.” JAMA. 288(3):321-33.
(*12) Family Practice News. (2003). 33(11), 1-2
(*13) Freedman D., (2010). Lies, Damned Lies, and Medical Science. The Atlantic. Nov 2010 Issue.
(*14) Ioannidis, J.P.A., (2005). Why Most Published Research Findings Are False. PLoS Med 2(8): e124. doi:10.1371/journal.pmed.0020124
(*15) Freedman D., (2010). Lies, Damned Lies, and Medical Science. The Atlantic. Nov 2010 Issue.
(*16) Csoka, A., (2015). Innovation in medicine: Ignaz the reviled and Egas the regaled. Med Health Care Philos. Springer Journal, Dec 4.
(*17) Wall Street Journal |Feb 25th 2009
(*18) Rogers, S., (2009). Total Wellness. Aug, p. 1.
(*19) Boden et al., (2007). New England Journal of Medicine. Optimal medical therapy with or without PCI for stable coronary artery disease. April 12, 356; 15:5003-16.
(*20) Evidence-Based Medicine Working Group. (1992). Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA, 268(2420), p. 2422.
(*21) Department of Clinical Epidemiology and Biostatistics, McMaster University. (1981). How to read clinical journals, II: to learn about a diagnostic test. Can Med Assoc J. 124:703-710.
(*22) Godfrey, K., (1985). Simple linear regression in medical research. N Engl J Med, 313, p. 1629-1636
(*23) Department of Clinical Epidemiology and Biostatistics, McMaster University. (1981). How to read clinical journals, V: to distinguish useful from useless or even harmful therapy. Can Med Assoc J, 124, 1156-1162.
(*24) Ibid
(*25) Ibid
(*26) University of North Carolina, Health Sciences Library. (2016). “Forming focused questions with PICO.”
(*27) Evidence-Based Medicine Working Group. (1992). Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA, 268, p. 2420.
(*28) Ibid
(*29) Ibid
(*30) Ibid
(*31) Cohen, D., (2013). “FDA official: Clinical trial system is broken.” BMJ, p. 347.
(*32) Turner, E., Matthews, A.M., Linardatos, E., Tell, R., Rosenthal, R. (2008). “Selective publication of antidepressant trials and its influence on apparent efficacy.” N Eng J Med, 358, p. 252-60.
(*33) Perlis, R.H. et al., (2005). “Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.” Am J Psychiatry, 162(10), p.1957-60.
(*34) Vigen, R., MD, MSCS1, et al., (2013). “Association of Testosterone Therapy with Mortality, Myocardial Infarction, and Stroke in Men with Low Testosterone Levels.” JAMA, 310(17), 1829-1836
(*35) Le Couteur, D.G., Doust, J., Creasey, H., Brayne, C. (2013). “Political drive to screen for pre-dementia: Not evidence based and ignores the harm of diagnosis.” BMJ, p. 347.
(*36) Allen, D., Harkins, K. (2005). “Too much guidance?” The Lancet, 365, p. 1768.
(*37) Greenhalgh, T., Howick, J., Maskrey, N. (2014). “Evidence-based medicine: A movement in crisis?” BJM. p. 348.
(*38) Roehr, B., (2012). “GlaxoSmithKline is fined record $3billion in US.” BMJ. 345, p. e4568.
(*39) Greenhalgh, T., Howick, J., Maskrey, N. (2014). “Evidence based medicine: A movement in crisis?” BMJ. p. 348.
(*40) Ibid
(*41) Shoemaker, R. (2010). Surviving Mold: Life in the Era of Dangerous Buildings. Otter Bay Books: Baltimore, p. 310-311.